A minor car accident can feel confusing. You may step out of the vehicle, check for damage, and think, “I feel okay.” But later that night, the next morning, or even a few days later, pain may begin. This is very common after motor vehicle accidents.
Delayed symptoms often appear 24 to 72 hours after a crash. Some symptoms may even show up weeks later. This happens because the body releases adrenaline and endorphins during stressful events. These chemicals can hide pain at first. Once the body calms down, inflammation, muscle tightness, nerve irritation, and joint stiffness can become easier to feel (Centers for Neurosurgery, Spine & Orthopedics, n.d.).
At ChiroMed, the goal is to help patients understand what their body may be telling them after a crash. Even a low-speed accident can affect the neck, back, muscles, joints, discs, and nerves. Early evaluation can help identify injuries before they become long-term problems.
Why You May Feel Fine Right After the Crash
During a motor vehicle accident, the body reacts fast. Your muscles tighten. Your heart rate goes up. Your brain focuses on safety. This stress response can make pain feel smaller than it really is.
Later, when the stress response slows down, symptoms may begin. Inflammation can increase. Muscles may spasm. Joints may stiffen. Nerves may become irritated. This is why someone may feel okay at the scene but wake up the next day with neck pain, headaches, low back pain, or stiffness.
Common delayed symptoms after a minor car accident include:
Neck stiffness or pain
Back pain or tightness
Headaches
Shoulder pain
Numbness or tingling in the arms or legs
Dizziness
Fatigue
Brain fog
Irritability
Trouble sleeping
Pain that gets worse with movement
Whiplash is one of the most common delayed injuries after a crash. Mayo Clinic explains that whiplash can cause neck pain, stiffness, headaches, dizziness, fatigue, and pain that radiates to the shoulder, arm, or upper back (Mayo Clinic, 2024).
Why Delayed Symptoms Should Not Be Ignored
Pain after a crash is not always just soreness. It can be a sign that the body has been injured. Soft tissues such as muscles, ligaments, tendons, and fascia can be stretched or strained. Spinal joints may lose normal motion. Discs may become irritated. Nerves may become compressed or inflamed.
Some symptoms may also point to a more serious issue. For example, a worsening headache, sudden weakness, confusion, recurrent dizziness, or new numbness should be taken seriously. The CDC notes that worsening headaches, weakness, numbness, poor coordination, repeated vomiting, confusion, or unusual behavior after a head injury can be danger signs that need urgent medical attention (Centers for Disease Control and Prevention, 2025).
Seek immediate medical care if you have:
Sudden weakness
Severe dizziness
Worsening headache
Confusion or slurred speech
New numbness or loss of coordination
Severe abdominal pain
Chest pain
Pain that becomes sharp, severe, or rapidly worse
These symptoms do not always mean something life-threatening is happening, but they should be checked quickly.
How ChiroMed Looks at Car Accident Recovery
ChiroMed’s approach to accident recovery focuses on the whole injury pattern, not just one painful area. After a crash, the body may create compensation patterns. This means one area becomes tight or overworked because another area is injured or not moving well.
For example, a neck injury may lead to shoulder tension. A low back injury may change the way a person walks. Muscle guarding may cause joint stiffness. Nerve irritation may create tingling or pain that travels into the arms or legs.
An integrative chiropractic care plan may look at:
Spinal alignment
Joint motion
Muscle tension
Posture
Nerve irritation
Range of motion
Strength and balance
Functional movement
Pain patterns after the crash
This type of care can help connect symptoms to the mechanics of the injury.
Chiropractic Care After a Minor Motor Vehicle Accident
Chiropractic care may help restore healthy movement after a crash. The goal is not only to reduce pain. The goal is also to improve how the spine, joints, muscles, and nerves work together.
After a motor vehicle accident, chiropractic care may include:
Gentle spinal adjustments
Soft tissue therapy
Myofascial release
Stretching and mobility work
Posture correction
Decompression when appropriate
Corrective exercise
Rehabilitation planning
Chiropractic adjustments and soft-tissue care may help reduce joint restrictions, improve mobility, and decrease stress on irritated tissues. This can be especially helpful when the body is guarding after a crash.
The Role of Medical Oversight in an Integrative Injury Clinic
An integrative injury clinic often includes more than one type of provider. This model can be helpful because car accident injuries may involve the spine, muscles, joints, nerves, inflammation, and overall health.
Dr. Maria Guadalupe Cardenas, MD, is described as a board-certified internal medicine physician, Medical Director, and Collaborative Physician for Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas. Her listed credentials include NPI #1164426749 and Texas MD License #J2933. This type of medical direction supports a multidisciplinary setup where internal medicine oversight works alongside chiropractic and injury care.
Dr. Alexander Jimenez, DC, APRN, FNP-BC, brings a combined focus in chiropractic care, nurse practitioner evaluation, functional medicine, rehabilitation, and personal injury care. His clinical observations often focus on identifying the root cause of pain, documenting injury patterns, and helping patients recover function after car accidents.
Together, this model helps support a more complete recovery plan. Chiropractic care can focus on biomechanics and movement. Medical oversight can help with broader clinical screening, internal medicine concerns, and coordination when referral or advanced evaluation is needed.
Functional Medicine and Recovery After a Crash
Functional medicine looks at how the whole body supports healing. After a car accident, inflammation, sleep problems, stress, nutrition, and metabolic health can all affect recovery.
A functional medicine approach may support:
Inflammation control
Better sleep
Tissue repair
Healthy weight support
Blood sugar balance
Nutrition for healing
Energy and recovery
This matters because the body needs the right healing environment. If a person is not sleeping, eating poorly, or dealing with high stress, recovery may take longer.
Regenerative Therapies and Soft Tissue Healing
Some patients may continue to have pain after the early injury phase. In certain cases, regenerative therapies may be discussed. These therapies are designed to support the body’s natural healing response.
Platelet-rich plasma, or PRP, is one example. PRP uses a patient’s own blood, which is processed to concentrate platelets. Platelets contain growth factors that may support tissue repair. The American Academy of Orthopedic Surgeons explains that PRP has been studied for musculoskeletal injuries, although results can vary depending on the condition, preparation, and patient factors (American Academy of Orthopedic Surgeons, n.d.).
A review of PRP in musculoskeletal medicine notes that PRP is used to support healing in certain bone and soft-tissue conditions, but it should be applied carefully and only when clinically indicated (O’Dowd et al., 2022).
Regenerative injections should not be presented as a guaranteed cure. They are one possible tool in a larger care plan. For many patients, the best results come from combining biological support with improved movement, posture, and spinal mechanics.
Why Regenerative Care and Chiropractic Care Can Work Together
Regenerative therapies may help support the healing environment at the cellular level. Chiropractic care and rehabilitation help improve the movement environment around the injured tissue.
This combination matters because injured tissue may stay irritated if the body keeps moving poorly. For example, if a joint is under too much stress, or if a muscle keeps guarding, healing may be slower. Chiropractic adjustments, myofascial release, posture correction, and rehab exercises may reduce abnormal stress on recovering tissues.
A combined plan may include:
Regenerative consultation when appropriate
Chiropractic adjustments
Myofascial therapy
Corrective exercise
Mobility training
Nutrition support
Functional medicine guidance
Progress tracking
This gives patients a more complete path to recovery.
Why Early Documentation Matters After an Accident
After a crash, documentation is important. A clear medical record can show when symptoms began, what areas were injured, what exam findings were present, and what care was recommended.
This matters for both health and personal injury cases. Delayed symptoms can be confusing if they are not recorded early. A patient may not feel much pain on day one, but symptoms may be stronger by day two or three. A proper evaluation helps connect the injury pattern to the accident timeline.
Good documentation may include:
Patient history
Accident details
Pain location
Range of motion findings
Neurological findings
Functional limitations
Imaging recommendations when needed
Treatment plan
Progress notes
This helps the care team track recovery and adjust treatment when needed.
What Patients Can Do in the First Few Days
The first few days after a crash are important. Do not ignore symptoms. Do not assume pain will always go away on its own. Listen to your body.
Helpful steps include:
Get evaluated by a healthcare provider
Write down symptoms each day
Avoid heavy lifting until cleared
Watch for worsening pain or nerve symptoms
Stay hydrated
Rest, but avoid staying completely inactive too long
Follow professional instructions
Seek urgent care for red-flag symptoms
A symptom journal can help. Write down when pain started, where it is located, what makes it worse, and whether it spreads into the arms or legs.
Conclusion: Minor Accidents Can Still Cause Real Injuries
Delayed symptoms after a minor motor vehicle accident are common. Pain may appear 24 to 72 hours later because adrenaline and endorphins can hide symptoms at first. Inflammation, muscle guarding, joint stiffness, and nerve irritation may become more noticeable after the body calms down.
ChiroMed’s integrative injury care approach focuses on understanding the full injury pattern. Chiropractic care, medical oversight, functional medicine, rehabilitation, personal injury care, and regenerative options may all play a role when clinically appropriate.
The goal is simple: reduce pain, restore movement, support healing, and help patients return to daily life with better function.
Gain insight into effective hypothyroidism diagnosis and management strategies for a healthier, more balanced life.
The Intricacies of Hypothyroidism: An Integrative Approach to Diagnosis and Management
Hello, I’m Dr. Alexander Jimenez. As a healthcare professional with a comprehensive background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), along with certifications in Advanced Toxinology (ATN) and Chiropractic Cranial Spinal Techniques (CCST), I am dedicated to exploring the intricate connections within the human body. My practice is rooted in integrating multiple disciplines to provide a holistic, patient-centered approach to wellness. Today, I want to guide you through a critical topic that affects millions: hypothyroidism. This condition, often characterized by a sluggish thyroid, can manifest in numerous ways, impacting everything from energy levels and mood to metabolic health. My goal is to guide you through the complexities of hypothyroidism, from its core physiology and subtle subclinical cases to more overt presentations, and demonstrate how a holistic, evidence-based approach can lead to optimal patient outcomes.
As we prepared this educational material, I am reminded of the importance of taking a steady, thoughtful pace in both our lives and our approach to health—a concept echoed by World Sauntering Day, which was celebrated a few years back on June 19th. This idea of “sauntering”—moving with mindful intention—perfectly encapsulates the careful, personalized journey we must take when addressing chronic conditions like hypothyroidism.
Abstract: Navigating Hypothyroidism with an Integrative Framework
This educational post provides a comprehensive, integrative perspective on hypothyroidism, one of the most common endocrine disorders seen in clinical practice. We will journey through the fundamental aspects of this complex condition, starting with its core definition, prevalence, and the crucial role of the hypothalamic-pituitary-thyroid (HPT) axis. We will differentiate between primary, secondary, and tertiary hypothyroidism, with a special focus on Hashimoto’s thyroiditis, the leading cause in the United States, while also touching upon the global impact of iodine deficiency. The discussion will cover the full spectrum of diagnosis, from patient history and physical examination to the interpretation of a comprehensive lab panel, including TSH, TPO antibodies, and thyroid hormone levels. We will delve into the nuances of overt versus subclinical hypothyroidism and outline a patient-centered treatment philosophy. A key focus will be on therapeutic options, from standard-of-care levothyroxine (T4) to liothyronine (T3) and desiccated thyroid extract, emphasizing the “low and slow” dosing strategy and proper medication administration. Finally, we will illuminate how integrative chiropractic care, combined with functional medicine principles, complements medical management by addressing the body’s structural and neurological integrity, thereby supporting overall physiological function and well-being.
Understanding Hypothyroidism: The Core Concepts
At its most fundamental level, hypothyroidism is a condition defined by the reduced production of thyroid hormone. Your thyroid gland, a small, butterfly-shaped organ located at the base of your neck, acts as the body’s master metabolic regulator. Its hormones, primarily thyroxine (T4) and triiodothyronine (T3), influence nearly every cell, controlling the speed of your metabolism, body temperature, heart rate, and much more. When hormone production falters, the entire system slows down.
Statistically, while overt (or clinical) hypothyroidism affects a relatively small portion of the population—about 0.1% to 2%—it is significantly more prevalent in women than in men. This gender disparity is a common theme in autoimmune diseases, and as we will see, autoimmunity is the primary driver of hypothyroidism in developed nations. From a functional medicine perspective, this statistic prompts us to ask why women are more susceptible, leading us to investigate the interplay of genetics, hormonal fluctuations (like those in pregnancy and menopause), and environmental triggers.
The HPT Axis: Your Body’s Thyroid Command Center
To truly grasp hypothyroidism, we must first understand the elegant feedback loop that governs thyroid function: the Hypothalamic-Pituitary-Thyroid (HPT) axis. Think of it as a three-part chain of command, or more simply, like a thermostat and a furnace.
The Hypothalamus: Located in the brain, the hypothalamus is the supreme commander. It constantly monitors the levels of thyroid hormone in your bloodstream. When it detects low levels, it releases Thyrotropin-Releasing Hormone (TRH).
The Pituitary Gland: TRH travels a short distance to the pituitary gland, the “master gland” also in the brain. The pituitary acts as the thermostat. In response to TRH, it secretes Thyroid-Stimulating Hormone (TSH) into the bloodstream.
The Thyroid Gland: TSH travels to the thyroid gland—the furnace—and signals it to produce and release T4 and T3. As these hormone levels rise in the blood, the hypothalamus and pituitary detect the increase and reduce their output of TRH and TSH, respectively. This negative feedback loop ensures that hormone levels remain in a stable, healthy range.
When we classify hypothyroidism, we do so based on where this chain of command breaks down.
Primary Hypothyroidism: This is by far the most common type. The problem lies directly within the thyroid gland itself. The gland has failed to produce enough hormone despite receiving clear signals (high TSH) from the pituitary. It’s like pressing the accelerator in a car, but the engine is broken.
Secondary Hypothyroidism: The issue originates in the pituitary gland. The thyroid gland is healthy and capable of producing hormones, but it isn’t receiving the TSH signal to do so. This can be caused by pituitary surgery, tumors, radiation, or even traumatic brain injury. Both TSH and thyroid hormone levels will be low.
Tertiary Hypothyroidism: This is the rarest form, where the problem starts at the very top—the hypothalamus. The hypothalamus is not producing enough TRH, so the pituitary never receives the signal to release TSH, and consequently the thyroid never receives the signal to produce its hormones.
Understanding this axis is crucial because it dictates our diagnostic approach. A simple TSH test tells us a lot, but a comprehensive panel including Free T4, Free T3, and thyroid antibodies gives us a much clearer picture of where the dysfunction is occurring.
Unpacking the Causes of Primary Hypothyroidism
In my clinical experience at El Paso’s injury and chiropractic clinic, I consistently emphasize the importance of obtaining a thorough, comprehensive history from every patient—because the underlying etiology directly informs how we manage and treat the condition.
Hashimoto’s Thyroiditis: The Autoimmune Culprit
In the United States and other countries with sufficient iodine intake, the overwhelming majority of primary hypothyroidism cases are caused by chronic lymphocytic autoimmune thyroiditis, better known as Hashimoto’s disease. This is an autoimmune condition in which the body’s immune system mounts a cell-mediated attack against thyroid tissue, progressively impairing the gland’s ability to produce T3 and T4. Research from leading immunologists like Fasano (2012) has illuminated the “leaky gut” or intestinal permeability model, which provides a framework for understanding how autoimmunity develops. In my practice, I find that addressing gut health, identifying food sensitivities, and managing chronic inflammation are foundational steps in managing Hashimoto’s.
Key clinical features include:
More common in women, with prevalence increasing with age.
Presence of anti-TPO antibodies (elevated in the majority of cases).
Association with other autoimmune diseases, including Addison’s disease, lupus, Sjogren’s syndrome, and rheumatoid arthritis.
Strong familial clustering with Hashimoto’s and Graves’ disease.
Iodine Deficiency: A Global Perspective
While Hashimoto’s is dominant in the U.S., on a global scale, iodine deficiency remains the most common cause of hypothyroidism. Iodine is an essential building block for thyroid hormones—T4 has four iodine atoms, and T3 has three. Without adequate iodine, the thyroid cannot synthesize these hormones, leading to hypothyroidism and often a goiter (an enlargement of the thyroid gland).
Other Acquired Causes of Hypothyroidism
Excessive Iodine Intake: While deficiency is a problem, so is excess. Consuming very high levels of iodine, sometimes from supplements like kelp or from exposure to medical contrast dyes, can paradoxically shut down thyroid hormone production in a phenomenon known as the Wolff-Chaikoff effect (Leung & Braverman, 2014).
Medication-Induced: Certain medications are well-documented disruptors. Lithium, used for bipolar disorder, inhibits hormone release (Bauer et al., 2020), and tyrosine kinase inhibitors used in oncology can also trigger dysfunction (Illouz et al., 2014). A thorough medication reconciliation is essential.
Post-Surgical or Post-Ablation: Patients who have undergone radioactive iodine ablation for Graves’ disease or have had a partial or total thyroidectomy will develop hypothyroidism. It is also important to think beyond direct thyroid procedures. Surgery or radiation therapy to the neck or chest region for other cancers can damage the gland.
Post-ICU Illness: Patients recovering from a severe medical illness, sometimes called “sick euthyroid syndrome”, may show temporary thyroid abnormalities. This typically resolves without intervention and requires careful monitoring rather than immediate treatment.
Congenital Hypothyroidism: A range of genetic and developmental disorders can impair thyroid function from birth. These are typically identified through newborn screening programs.
“Cracking the Low Thyroid Code: A Comprehensive Assessment Guide”-Video
The Pituitary and Hypothalamic Connection: Beyond the Thyroid
Sometimes, the problem isn’t in the thyroid itself. One of the most clinically underrecognized causes I have encountered in my practice involves post-concussive pituitary injury. The pituitary gland sits on a delicate stalk. During a significant head impact, the mechanical force can disrupt its function. I evaluated a law enforcement officer who, two years after a closed head injury from a high-speed pursuit, developed pituitary dysfunction directly attributable to the trauma. This case underscores the importance of longitudinal follow-up for patients with a history of head trauma or repeated concussions, as delayed-onset hypopituitarism is well-documented (Kokshoorn et al., 2011).
Diagnosing Hypothyroidism: History, Labs, and Clinical Judgment
A thorough history remains the cornerstone of evaluation. Key areas to explore include radiation exposure, neck surgery, new medications, family history of thyroid disease, and dietary changes, particularly iodine-rich supplements.
Key Physical Examination Findings
A systematic thyroid exam involves inspection, palpation (from both the anterior and posterior aspects, with the patient swallowing), and auscultation. In my practice at chiromed.com, this comprehensive approach is standard. Physical signs of hypothyroidism can include:
Bradycardia (slowed heart rate)
Delayed deep tendon reflex relaxation (a hallmark sign)
Periorbital puffiness and myxedematous facial features
Thickened, dry skin, coarse hair, and alopecia (hair loss)
Diastolic hypertension
Enlarged tongue and hoarseness in more advanced cases
Interpreting the Thyroid Panel and Imaging
The core laboratory tests provide a window into the HPT axis.
Test
Clinical Significance
TSH
Primary screening test; reference range 0.4–4.5 mIU/L
Free T4
Evaluates circulating unbound thyroxine
Free T3
Active hormone; assesses peripheral conversion
Anti-TPO antibodies
Elevated in 85–90% of Hashimoto’s cases
Antithyroglobulin antibodies
May be elevated in autoimmune thyroid disease
Hypothyroidism can also cause systemic lab changes, including anemia, hyperlipidemia (elevated cholesterol), hyponatremia (low sodium), and elevated creatine kinase (CK).
Thyroid ultrasound is the imaging modality of choice. In Hashimoto’s, the gland is often diffusely enlarged (goiter) with a heterogeneous echotexture and may show hypoechoic micronodules.
The Challenge of Subclinical Hypothyroidism
One of the more perplexing areas is subclinical hypothyroidism. This is the most common thyroid function abnormality, characterized by an elevated TSH (typically 5-10 mIU/L) with a normal free T4. The decision to treat is not based on labs alone. We must consider the patient’s symptom burden, cardiovascular risk factors (as subclinical hypothyroidism is associated with elevated LDL cholesterol), and the presence of TPO antibodies, which suggest likely progression to overt disease (Rodondi et al., 2010).
It is also critical to distinguish between “Wilson’s temperature syndrome,” a diagnosis not recognized by the American Thyroid Association, and Wilson’s disease, a serious inherited disorder of copper metabolism. These are entirely distinct clinical entities.
The Goals and Strategies of Hypothyroidism Treatment
When a patient is diagnosed with hypothyroidism, our treatment goals are multifaceted:
Symptom Resolution: Alleviating fatigue, weight gain, brain fog, and depression.
Normalization of Biomarkers: Normalizing serum TSH and improving T4 and T3 concentrations.
Avoiding Overtreatment: Preventing iatrogenic thyrotoxicosis (overactive thyroid function from medication), which is especially dangerous for older patients.
The Thyroid-Cholesterol Connection: Treat the Thyroid First
A crucial and often overlooked consequence of hypothyroidism is its impact on lipid metabolism. Hypothyroidism is a common cause of secondary dyslipidemia, leading to elevated triglycerides and Lipoprotein(a) or Lp(a), a potent cardiovascular risk factor. A key principle I’ve learned from my collaborative work in cardiometabolic health is: treat the thyroid first. Before aggressively treating cholesterol, we must optimize thyroid function. Correcting hypothyroidism often leads to a spontaneous improvement in cholesterol levels, creating a stable metabolic foundation.
First-Line Treatment: The Role of Levothyroxine (T4)
The cornerstone of treatment, as recommended by the American Thyroid Association (ATA), is synthetic levothyroxine (T4) (Jonklaas et al., 2014). T4 has a long half-life of five to seven days, providing stable blood levels. The body then naturally converts this storage hormone into the active T3 hormone as needed. For consistency, the ATA has expressed a preference for patients to remain on a specific brand-name product (e.g., Synthroid®, Levoxyl®) due to the narrow therapeutic index of thyroid hormone.
Exploring Other Therapeutic Options: T3 and Desiccated Thyroid
While T4 monotherapy is the standard, it’s not a one-size-fits-all solution.
Liothyronine (T3) Therapy: Synthetic T3 is the active hormone. It has a short half-life and is more potent, making dosing challenging. It is sometimes added to a T4 regimen (combination therapy) for patients who may have issues converting T4 to T3.
Desiccated Thyroid Extract (DTE): Derived from pig or cow thyroid glands (e.g., Armour® Thyroid), DTE contains a combination of T4, T3, and other compounds. While not a first-line therapy, it is a viable option for patients who do not respond well to T4 alone.
The Art of Dosing: “Go Low and Slow”
The most important principle in initiating and adjusting medication is to “go low and slow.” The body needs time to acclimatize to the increased metabolic rate. We typically use a weight-based calculation of 1.6-1.8 mcg per kilogram of body weight to estimate the final dose, but we never start at this level. We begin with a low dose (e.g., 25-50 mcg), wait six to eight weeks for levels to stabilize, and then recheck the TSH. It is paramount to treat the patient, not the paper. If a patient’sTSH is “normal” but they feel unwell, we must investigate further.
Proper Medication Administration: The Key to Success
The effectiveness of thyroid medication depends heavily on how it’s taken. The golden rules are:
Take it on an empty stomach first thing in the morning.
Take it with a full glass of water only.
Wait 45-60 minutes before eating or drinking anything else (including coffee).
Take it separately from other medications and supplements, especially iron and calcium, by at least four hours.
Special Considerations: Amiodarone and Adrenal Insufficiency
Amiodarone, an antiarrhythmic drug, is notorious for causing thyroid problems due to its high iodine content and direct toxicity. Patients on this drug require very close monitoring.
It is critical to be aware of potential adrenal insufficiency (Addison’s disease). Starting thyroid hormone in a patient with undiagnosed Addison’s can precipitate a life-threatening adrenal crisis.
Clinical Case Studies: An Integrative Approach in Action
Case Study 1: Sally, The Young Graduate Student with Hashimoto’s
Sally, a 24-year-old graduate student, presented with fatigue, weight gain, and depression. Her mother had Hashimoto’s. Her labs showed a TSH of 6.0, normal T4, and TPO antibodies of 1,100. Her thyroid ultrasound was consistent with autoimmune thyroiditis. She was diagnosed with subclinical hypothyroidism secondary to Hashimoto’s disease.
Instead of starting a high dose, we adhered to the “go low and slow” principle and began with just 25 micrograms of levothyroxine daily. At her six-week follow-up, she felt remarkably better, and her TSH had normalized to 2.5. Her integrative plan also included an anti-inflammatory, gluten-free diet and chiropractic care to manage stress and support neurological function.
Case Study 2: Jane, Unraveling Treatment Complexity
Jane, a 52-year-old postmenopausal woman, presented with fatigue and weight gain despite being on 112 mcg of levothyroxine. Her TSH was elevated at 12. Her history was significant for breast cancer treated with chest radiation, and her thyroid ultrasound showed an atrophic (shrunken) gland. While a dose increase to 125 mcg was indicated, the more important question was why her TSH suddenly increased. After a thorough investigation into medication adherence, formulation changes, and potential GI absorption issues, we increased her dose. Her TSH normalized, and her symptoms improved, underscoring the importance of active, investigative management.
The Role of Integrative Chiropractic Care in Thyroid Health
You might wonder, “How does chiropractic care fit into managing a hormonal condition?” The connection lies in the intricate relationship among the nervous, endocrine, and musculoskeletal systems.
An integrative chiropractic approach goes beyond simple spinal adjustments. We focus on restoring optimal function to the entire body.
Neuro-Endocrine Connection: The HPT axis is regulated by the central nervous system. Chronic stress—processed by the nervous system—can disrupt hypothalamic and pituitary function. Misalignments in the spine, particularly in the cervical (neck) region (vertebral subluxations), can create neurological interference. Gentle, specific chiropractic adjustments can help reduce this interference and promote better balance in the autonomic nervous system.
Reducing Systemic Inflammation: Inflammation is a key driver of Hashimoto’s. Structural imbalances contribute to chronic physical stress and low-grade systemic inflammation. By correcting spinal alignment and improving biomechanics, chiropractic care can help modulate the inflammatory response (Alcantara & Alcantara, 2012).
Holistic Patient Management: As a practitioner with dual certifications, I integrate chiropractic adjustments with nutritional counseling, stress management, and targeted supplementation. For instance, we may identify a need for selenium and zinc, which are crucial for T4-to-T3 conversion, or recommend an anti-inflammatory diet. This comprehensive strategy, which we employ at our El Paso clinic, addresses root causes rather than just managing symptoms. In my clinical experience, patients who incorporate integrative chiropractic care often report improved energy, reduced pain, and a greater sense of well-being.
Conclusion: A Holistic Framework for Thyroid Health
Hypothyroidism is a complex, multifactorial condition that demands clinical precision, comprehensive evaluation, and an integrative treatment perspective. From the foundational physiology of the HPT axis to the nuanced presentations of Hashimoto’s thyroiditis, subclinical hypothyroidism, and post-concussive pituitary dysfunction, every patient requires an individualized approach. By combining thorough history-taking, targeted laboratory evaluation, and integrative chiropractic care, clinicians can deliver outcomes that go far beyond simply normalizing a TSH value—restoring genuine physiological balance and patient well-being.
Leung, A. M., & Braverman, L. E. (2014). Consequences of excess iodine. Nature Reviews Endocrinology, 10(3), 136–142.
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Asvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., Bremner, A., Maisonneuve, P., Sgarbi, J. A., Khaw, K.-T., Vanderpump, M. P. J., Newman, A. B., Cornuz, J., Franklyn, J. A., Eastell, R., … Gussekloo, J. (2010). Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA, 304(12), 1365–1374.
SEO Tags: Hypothyroidism, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Hashimoto’s Thyroiditis, Thyroid Health, HPT Axis, Primary Hypothyroidism, TSH, Thyroid Hormones, Autoimmune Disease, Chiropractic Adjustment, Systemic Inflammation, Holistic Health, El Paso TX, Functional Medicine Practitioner, hypothyroidism causes, subclinical hypothyroidism, thyroid stimulating hormone, TPO antibodies, secondary hypothyroidism, pituitary dysfunction concussion, thyroid examination technique, thyroid ultrasound findings, hypothyroidism diagnosis, anti-TPO antibodies Hashimoto’s, congenital hypothyroidism, Hypothyroidism Treatment, Levothyroxine, T4 Therapy, Liothyronine, T3 Therapy, Desiccated Thyroid Extract, Thyroid and Cholesterol, Amiodarone Thyroid Dysfunction, Adrenal Insufficiency, Low and Slow Dosing, Cardiometabolic Disease
Discover effective methods for musculoskeletal health recovery and regeneration to improve your strength and vitality.
Abstract
In this educational post, I share my first-hand, clinical perspective on how supplements, nutrition, hormones, stress, and integrative chiropractic care can support patients with joint pain and recovery—especially those undergoing platelet-rich plasma (PRP) or other orthobiologic procedures. Drawing on the latest evidence and leading research, I outline what we know (and do not yet know) about popular supplements like glucosamine, chondroitin, and turmeric; why timing around biologic procedures matters; how Mediterranean-pattern diets support musculoskeletal health; and the essential roles of sleep, stress management, and hormone balance. I also explain how integrative chiropractic strategies—spinal and extremity joint manipulation, soft-tissue therapies, neuromotor retraining, and graded loading—fit into modern, evidence-based care. Throughout, I include practical protocols I use in practice and observations from patient care in active adults, including older athletes. My goal is to equip you with a clear, step-by-step roadmap to personalize care while minimizing unknowns and maximizing outcomes.
Evidence-Based Supplement Use Around Joint Pain and Biologics
As a clinician working with active adults—think devoted skiers and pickleball enthusiasts—I’m frequently asked about supplements for pain, stiffness, and fatigue. Patients often come in taking multiple over-the-counter products, hoping to stay on the court or the slopes. My approach follows a structured, evidence-forward conversation: clarify what we know, define what we do not know, and tightly control variables around regenerative procedures. Key premise: Supplements can be helpful for some, but research is mixed. We must consider timing, quality, safety, and interactions—especially around biologic interventions such as PRP.
Glucosamine and Chondroitin: What the Data Suggest
What they are: Building blocks associated with cartilage matrix metabolism. Proposed mechanisms: Glucosamine may modulate chondrocyte activity and inflammatory signaling (e.g., NF-κB), affecting proteoglycan synthesis. Chondroitin may support cartilage matrix integrity and exert mild anti-inflammatory effects. Evidence summary: Osteoarthritis research shows variable results. Some meta-analyses suggest modest improvements in pain and function, particularly with pharmaceutical-grade chondroitin and glucosamine sulfate, while others find minimal to no clinical benefit (Zhang et al., 2016; Roman-Blas et al., 2017). My clinical protocol: Trial duration: 8 weeks. That timeframe aligns with many study designs and allows meaningful assessment of symptom change. Counseling: Set realistic expectations. I emphasize that benefits, if they occur, are often modest and more noticeable in knee OA than in other joints. Quality control: Prefer single-ingredient products from reputable manufacturers with third-party testing. Why this matters physiologically: In OA, low-grade inflammation and matrix degradation promote pain and stiffness. If these compounds reduce catabolic signaling or support anabolic processes, patients may experience symptom relief. Citations: Efficacy and safety of glucosamine and chondroitin for the treatment of osteoarthritis (Zhang et al., 2016); Chondroitin sulfate and glucosamine in the management of osteoarthritis (Roman-Blas et al., 2017).
Turmeric/Curcumin: Anti-Inflammatory Potential and Timing Nuances
What it is: Curcumin, the active constituent in turmeric, can modulate COX-2, LOX, TNF-α, IL-6, and NF-κB, with downstream effects on nociceptive signaling and synovial inflammation. Evidence summary: Multiple randomized trials indicate that curcumin can reduce pain and improve function in knee OA, with effect sizes comparable to those of NSAIDs in some studies, but a generally better GI safety profile (Onakpoya et al., 2017; Daily et al., 2016). Timing around biologics: I often recommend a trial off curcumin for approximately 2 weeks before and after PRP. The rationale: anti-inflammatory agents may theoretically blunt the early inflammatory signaling that initiates the regenerative cascade in PRP. Importantly, the evidence on timing is mixed; some patients who choose to continue still do well. But when we can, we control for confounders to interpret the procedure’s effect better. Physiological rationale: Early PRP phases involve controlled inflammation: platelet activation releases growth factors (PDGF, TGF-β, VEGF), chemokines, and cytokines that recruit reparative cells. Dampening this phase too aggressively could theoretically reduce signal strength. Citations: Efficacy of curcumin for knee osteoarthritis: systematic review and meta-analysis (Onakpoya et al., 2017); Turmeric extract curcumin in the management of osteoarthritis: systematic review and meta-analysis (Daily et al., 2016).
Beyond Adjustments: Chiropractic and Integrative Healthcare
The Supplement Unknowns: Respecting Uncertainty
Many patients take a “stack” of supplements without clear evidence regarding interactions with biologics. My message: There are supplements we know are safe, those we think are safe, and a large category where we do not know. Around a PRP or orthobiologic procedure, I aim to control variables so we can attribute outcomes to the intervention. Practical strategy: Prepare a complete supplement inventory. Pause non-essential supplements 1–2 weeks pre-procedure and 1–2 weeks post-procedure, unless medically necessary. Reinstate one at a time if needed, monitoring symptoms and function.
PRP and Orthobiologics: Why Variable Control Matters
I primarily work with PRP and see excellent outcomes in carefully selected patients. To maximize effect size and interpret outcomes: Control pre/procedural variables: Limit systemic NSAIDs pre/post PRP (typically stop 3–7 days prior and for 1–2 weeks after unless otherwise directed). Pause high-potency anti-inflammatory supplements (e.g., curcumin, high-dose omega-3s) in the immediate window. Optimize sleep, hydration, and protein intake to support repair. Biological rationale: PRP depends on a sequential healing response: hemostasis and inflammation (hours–days), proliferation (days–weeks), and remodeling (weeks–months). Each phase relies on intact signaling from platelets, immune cells, and tenocytes/chondrocytes/synoviocytes. Excessive suppression of inflammation early may attenuate chemotaxis and growth factor bioactivity; conversely, excessive inflammation can also be detrimental. We are aiming for a controlled milieu. Recent PRP guidance supports NSAID avoidance around procedures to preserve platelet function and inflammatory signaling (Chahla et al., 2021). While supplement-specific data are sparser, the same logic applies: reduce pharmacologic and nutraceutical confounders in the peri-procedural window. Citation: Guidelines for the Use of Platelet-Rich Plasma in Orthopedics (Chahla et al., 2021).
Nutrition Foundations: Mediterranean Patterns and Tissue Health
When we step back from individual supplements, nutrition offers some of the most consistent, cross-disciplinary support for musculoskeletal health.
Why a Mediterranean or Green Mediterranean Pattern?
Hallmarks: high intake of vegetables, fruits, legumes, whole grains, nuts, olive oil; moderate fish; limited refined carbohydrates and processed meats. The green Mediterranean variant emphasizes additional polyphenols (e.g., green tea, Mankai, walnuts) and reduced red meat. Evidence highlights: Reduced systemic inflammation (lower CRP/IL-6). Improved metabolic health—central to joint load and recovery. Neurologic and cardiometabolic benefits with downstream effects on pain sensitivity and resilience (Estruch et al., 2018; Shai et al., 2022). Mechanisms relevant to joints: Improved endothelial function and microcirculation aid nutrient delivery to hypovascular tissues (tendons, meniscus). Polyphenols modulate oxidative stress and NF-κB signaling, potentially lowering synovitis. Omega-3-rich fish contribute to pro-resolving mediators (resolvins, protectins) that help terminate inflammation appropriately rather than blunt it outright. My clinical approach: I coach patients on a Mediterranean template, then personalize macros to activity level and joint goals. Protein targets: 1.2–1.6 g/kg/day for active adults and those in rehab to support collagen and myofibrillar protein synthesis. Collagen plus vitamin C: 10–15 g of gelatin or collagen with 50–100 mg of vitamin C, taken 30–60 minutes before tendon/ligament loading sessions, may support collagen cross-linking via proline/lysine hydroxylation (Shaw et al., 2017). Citations: Primary prevention of cardiovascular disease with a Mediterranean diet (Estruch et al., 2018); Green-Med diet and visceral adiposity (Shai et al., 2022); Dietary collagen/gelatin and tendon collagen synthesis (Shaw et al., 2017).
Sleep and Stress: The Unsung Drivers of Pain and Recovery
One of the strongest yet underappreciated determinants of outcomes is stress management—and, closely related, sleep quality.
Stress Physiology and Pain
Chronic stress elevates HPA axis tone, increasing cortisol variability, impacting immune signaling, and sensitizing nociceptive pathways (central and peripheral). Elevated anxiety and PTSD symptoms correlate with worse pain trajectories and slower recovery. Screening tools (e.g., PCL-5 for PTSD symptoms, GAD-7 for anxiety) can help identify at-risk patients. Clinical implication: When patients have high anxiety or PTSD symptom burden, I prepare them for a longer recovery arc and incorporate stress-reduction strategies early.
Evidence-Based Stress Interventions
Mindfulness-based stress reduction (MBSR), cognitive behavioral therapy for insomnia/pain (CBT-I/CBT-P), breathing-based HRV training, and graded exposure reduce pain-related distress and improve function (Cherkin et al., 2016; McCracken & Morley, 2014). Physiologic mechanisms: Improved prefrontal-limbic regulation reduces central sensitization. Parasympathetic activation modulates inflammatory cytokine output and restores autonomic balance, thereby supporting tissue healing.
Sleep as a Therapeutic Target
Aim for 7–9 hours with consistent timing. Sleep restriction amplifies pain sensitivity via adenosinergic and dopaminergic mechanisms and increases pro-inflammatory cytokines (Haack et al., 2012). Protocol: Sleep hygiene, stimulus control, dim light in the evening, morning light exposure, and CBT-I where needed. In athletes, optimize sleep opportunity around high-load training and post-procedure windows. Citations: Mindfulness-based stress reduction vs cognitive behavioral therapy vs usual care (Cherkin et al., 2016); Psychological treatments for chronic pain (McCracken & Morley, 2014); Sleep and pain sensitivity (Haack et al., 2012).
Hormones and Musculoskeletal Recovery: An Emerging Frontier
Hormonal milieu shapes tissue repair, pain perception, and training adaptation. Thyroid: Hypothyroidism is associated with myalgia, tendinopathy risk, and impaired collagen turnover. Normalizing thyroid function can improve energy, thermogenesis, and repair capacity (Cakir et al., 2003). Sex hormones: Estrogen influences ligament laxity and collagen metabolism; fluctuations can modulate ACL injury risk and tendon mechanics. Testosterone supports protein synthesis, erythropoiesis, and neuromuscular function; deficiency can impair recovery. Metabolic hormones: Insulin/IGF-1 pathways are crucial for collagen synthesis; insulin resistance impairs tenocyte responsiveness. Vitamin D modulates muscle function and immune signaling; insufficiency correlates with higher pain and slower recovery. Clinical takeaways: Screen symptomatic patients for thyroid function, vitamin D status, and signs of hypogonadism or estrogen imbalance. Address deficiencies conservatively and in coordination with primary or endocrine care. The goal is to restore physiologic balance, not supra-physiologic levels. Citations: Hypothyroidism and musculoskeletal manifestations (Cakir et al., 2003).
Integrative Chiropractic Care: Where Manual Therapy Meets Modern Rehab
As a doctor of chiropractic and nurse practitioner, I weave manual therapy, movement, and biologic strategies into a cohesive plan. This is where I see patients truly thrive.
Why Spinal and Extremity Joint Manipulation?
Target: joint dysfunction, altered afferent input, and reflexive muscle guarding. Mechanisms: Neurophysiologic: High-velocity, low-amplitude (HVLA) thrusts modulate dorsal horn excitability, descending inhibitory pathways, and improve sensorimotor integration. Patients often report immediate changes in pain and range of motion. Biomechanical: Restoring motion can redistribute loads away from sensitized tissue and improve arthrokinematics. Clinical rationale: In knee OA or tendinopathy, optimizing hip, ankle, and spinal mechanics alters kinetic chain forces, reducing focal overload.
Soft-Tissue Techniques and Myofascial Work
Instrument-assisted soft tissue mobilization, active release, and myofascial decompression address fascial adhesions, improve local perfusion, and reduce nociceptor activation. Physiologic effects: Mechanotransduction influences fibroblast alignment and collagen remodeling. Shear and compression improve tissue gliding and lymphatic clearance.
Neuromotor Retraining and Graded Loading
I pair manual therapy with graded exposure and progressive loading tailored to the tissue: Tendon: Heavy slow resistance (HSR) to promote collagen alignment and improved stiffness. Cartilage: Low-impact cyclical loading (cycling/elliptical) within pain-guided limits to stimulate chondrocyte metabolism without overload. Spine: Motor control and endurance for deep stabilizers (multifidus, transverse abdominis) to reduce recurrence risk. Rationale: Mechanical loading is the language of connective tissue. Dose and direction matter. We structure loading to signal adaptation without provoking inflammation beyond physiologic levels.
Where This Fits With PRP and Orthobiologics
Pre-procedure: Normalize movement patterns to minimize aberrant forces that could impair post-procedure gains. Early post-procedure: Protect and gradually reintroduce motion—emphasize isometrics and sub-symptom mobility to maintain neuromotor control. Mid to late rehab: Progress to functional loading aligned with sport demands. These strategies align with evidence supporting manual therapy plus exercise for spine and extremity pain and with regenerative principles that rely on appropriate mechanostimulation for tissue remodeling (Bialosky et al., 2018; Malliaras et al., 2013). Citations: Spinal manipulation mechanisms and clinical implications (Bialosky et al., 2018); Loading programs for tendinopathy (Malliaras et al., 2013).
Practical Protocol: How I Counsel Active Adults, Including Older Athletes
From years of working with motivated athletes—particularly my 60-plus crew determined to keep playing pickleball and skiing—I follow a structured protocol to keep them moving and recovering well. Assessment and Variable Control Comprehensive review of current medications and supplements; identify essential vs optional. If planning PRP/orthobiologics: Stop NSAIDs and high-dose anti-inflammatory supplements per protocol. Discuss the temporary pause of turmeric/curcumin and high-dose omega-3s in the immediate peri-procedural window. Set an 8-week trial for glucosamine/chondroitin if indicated. Nutrition and Hydration Adopt a Mediterranean or green Mediterranean pattern. Protein at 1.2–1.6 g/kg/day; prioritize leucine-rich sources. Consider collagen-plus-vitamin C pre-loading sessions for tendon/ligament rehab. Sleep and Stress Target 7–9 hours, standardize bedtime/wake time. Screen for anxiety/PTSD symptom burden (e.g., PCL-5, GAD-7). Introduce MBSR, paced breathing (4- 6 breaths/min), and CBT-I resources. Integrative Chiropractic and Rehab Apply spinal/extremity manipulation as indicated for mobility and pain modulation. Utilize soft-tissue methods to restore glide and reduce nociception. Progress through graded loading: isometrics → isotonic HSR → energy storage and release drills for athletes. Expectation Management Explain timing: PRP benefits often unfold over weeks to months as tissue remodeling progresses. If high stress or anxiety is present, prepare for a longer, more variable recovery—and put extra emphasis on stress interventions. Return-to-Play Criteria Symptom-guided, function-based metrics: Pain ≤ 2/10 during and after activity. Strength symmetry ≥ 90% when relevant. Hop or functional tests for lower extremity; trunk endurance benchmarks for spine.
What We Know vs What We Don’t: Communicating with Clarity
Patients deserve transparency. Here’s how I frame the conversation: What we know: Lifestyle pillars—nutrition, sleep, exercise, stress management—provide broad benefits and likely potentiate the effects of biologic therapies. Certain supplements, such as curcumin, show anti-inflammatory benefits for OA symptoms; glucosamine/chondroitin may help select patients. NSAIDs around PRP likely interfere with platelet function; caution is warranted. What we don’t fully know: How many supplement combinations interact with PRP or other biologics. The exact impact of anti-inflammatory nutraceuticals on early PRP signaling. The magnitude of hormonal modulation on specific orthobiologic outcomes (though physiology suggests relevance). Why careful timing: Peri-procedural periods are when signal fidelity matters. We pare back potential confounders to protect the therapeutic signal and evaluate outcomes honestly.
Clinical Observations from Practice
Across my practice, I’ve observed consistent patterns that align with the evidence and inform how I personalize care. Active older adults who are diligent about sleep and stress adaptation generally report smoother recoveries and fewer flares. Patients who embrace Mediterranean-style eating often experience improved energy, reduced morning stiffness, and better glycemic control—factors that support cartilage and tendon health. When we temporarily pause curcumin and other potent anti-inflammatories around PRP, I see clearer response curves. While not universal, outcomes often appear more predictable. Integrative chiropractic care that couples manipulation with progressive loading yields more durable improvements than passive care alone. The combination seems to recalibrate pain processing while also addressing mechanical load distribution. Patients with high anxiety or PTSD symptom loads reliably require more time and reassurance after procedures. Front-loading coping strategies makes a tangible difference in their trajectory. For additional insights into my clinical approach, visit my practice site and professional profile on LinkedIn. Practice: https://chiromed.com/ Professional profile: https://www.linkedin.com/in/dralexjimenez/
Putting It All Together: A Cohesive, Patient-Centered Plan
Integrating supplements, biologics, nutrition, hormones, stress, and chiropractic care is not about throwing everything at the problem. It is about: Sequencing: Knowing when to dial back anti-inflammatories around biologics to respect the body’s healing phases. Personalization: Matching diet, sleep, and rehab to individual needs and constraints. Mechanistic alignment: Ensuring our interventions support, rather than compete with, each other’s physiological aims. Measurement: Tracking pain, function, and validated psychometric scales to guide progress. When patients and clinicians partner around these principles, we see a consistent pattern: fewer setbacks, clearer progress, and a return to the activities that bring joy—whether that’s a crisp carve on a blue run or a well-placed dink at the kitchen line.
In this educational post, I will take you on a journey into the future of musculoskeletal treatment, moving beyond isolated symptom management to a comprehensive, whole-body paradigm. We will explore interventional orthopedics, which uses precise, image-guided techniques to target the root causes of pain. Building on this, I will introduce a concept I call functional orthopedics and the functional unit approach—a philosophy that integrates the principles of osteopathic medicine, physical medicine, and regenerative science. This approach emphasizes understanding the intricate connections between structure and function, the body’s innate healing capacities, and the importance of treating the entire biomechanical chain rather than just the site of pain. We will delve into the latest evidence-based research by leading experts, examining the critical roles of subchondral bone, intraosseous injections, and comprehensive treatment strategies for conditions such as osteoarthritis. By combining these advanced concepts with the foundational principles of integrative chiropractic care, we can create truly personalized and effective treatment plans that offer lasting relief and restore optimal function.
Understanding the “How” and “Why” of Modern Musculoskeletal Treatment
Thank you for joining me on this exploration of a truly transformative approach to musculoskeletal health. What we are about to discuss is an integral part of a new way of thinking in medicine, and I believe it can fundamentally change how we help our patients heal. Today, we’re not just talking about another treatment method; we’re diving into the “how, why, and what” of a more profound, evidence-based strategy.
The How: The “how” is our interventional orthopedic approach.
The Why: The “why” is rooted in functional orthopedics and the functional unit approach.
The What: The “what” is the application of these principles to deliver comprehensive, patient-centered care.
Let’s unpack what this all means for you and your health journey.
What is Interventional Orthopedics?
Interventional orthopedics represents a significant evolution from traditional pain management. It’s a specialized field that focuses on using the body’s own healing potential to repair and regenerate damaged tissue. The core principle is precision. Instead of just managing symptoms, we aim to treat the underlying source of the problem.
This isn’t about simply injecting a painful joint and hoping for the best. It’s about a meticulous process in which we use advanced imaging, such as ultrasound and fluoroscopy, to visualize and precisely target specific structures. Whether it’s a torn ligament, a damaged tendon, or degenerative changes within a joint, we can deliver orthobiologic treatments—such as Platelet-Rich Plasma (PRP) or Bone Marrow Aspirate Concentrate (BMAC)—directly to the site of injury with pinpoint accuracy.
The goal is to move beyond treating “the thing that is causing the pain” and instead look at the entire picture. But how do we decide what to target? That’s where the “why” comes into play.
Introducing Functional Orthopedics: A Philosophy of Whole-Body Healing
This brings me to a concept that is the cornerstone of my clinical philosophy: functional orthopedics. While you might not find this term in a standard medical textbook (I coined it to describe my integrated approach), its principles are not new. They are deeply rooted in my training as an osteopathic physician, a chiropractor, and a functional medicine practitioner.
Functional orthopedics is guided by several core tenets:
The body is a unit: No part of the body exists in isolation. A problem in your foot can affect your knee, which can in turn impact your hip and spine. Everything is connected.
Structure and function are interrelated: The way your body is built (structure) directly influences how it moves and operates (function), and vice versa. An imbalance in one will inevitably affect the other.
The body has self-healing mechanisms: it possesses an incredible, innate ability to heal and regenerate. The role of a physician is to facilitate and optimize these natural processes.
Rational treatment is based on these principles: The most effective and lasting treatments are those that honor and work with the body’s integrated design.
This philosophy is a synthesis of my background in Physical Medicine & Rehabilitation (PM&R), which focuses heavily on structure and function, and regenerative medicine, which harnesses the body’s self-healing capabilities. By applying the functional medicine model, we look for the root causes of a condition, considering all the factors—biomechanical, nutritional, and environmental—that contribute to a patient’s health state.
The Functional Unit Approach: Treating the System, Not Just the Symptom
The practical application of functional orthopedics is what I call the functional unit approach. This concept was first described in an old surgical textbook by Dudley and White, who defined the “functional spinal unit” (Dudley & White, n.d.). They recognized that treating a single vertebra or disc was often insufficient because the spine functions as an interconnected system.
We now see this comprehensive approach being validated by modern research in orthobiologics. Several recent studies have demonstrated the superior, long-term benefits of treating the entire functional unit of the spine. For example, researchers have published compelling papers on the use of PRP and BMAC not only in the epidural space but also in the facet joints, ligaments, and paraspinal muscles to treat lumbar and cervical spine issues (Centeno et al., 2017). By addressing all the components that contribute to spinal stability and function, patients experience more profound and lasting results.
This isn’t limited to the spine. A landmark study on knee osteoarthritis compared outcomes between patients who received only an intra-articular (in-joint) injection and those who received both intra-articular and extra-articular (outside the joint) treatments. The results were clear: while both groups improved, the group treated more comprehensively experienced significantly better and more durable outcomes (Centeno et al., 2020).
Think about it from a clinical perspective. How many times have I seen a patient with mild knee osteoarthritis who also has pes anserine bursitis, hamstring tendinopathy, or tenderness along the ligaments? Pain isn’t just coming from the joint space. It’s coming from the entire functional unit that supports and moves that joint. The paradigm shift is from a narrow, intra-articular focus to a comprehensive view encompassing all intra-articular and extra-articular structures.
Beyond the Joint: The Critical Role of Subchondral Bone
But does it stop there? The answer is no. A growing body of research is revealing another crucial layer to this puzzle, especially in osteoarthritis: the subchondral bone. This is the layer of bone directly beneath the cartilage.
For decades, the conventional wisdom propagated to patients was that osteoarthritis is primarily a disease of cartilage loss. We’ve all heard patients say, “My doctor told me I’m bone on bone” or “My cartilage is gone.” However, we also know that the degree of cartilage loss on an X-ray does not always correlate with the level of pain a person experiences.
So what’s the missing link? It’s often the health of the subchondral bone. When cartilage wears away, the underlying bone is exposed to increased stress and inflammation. This bone is not inert; it’s a living, dynamic tissue rich with blood vessels, nerves, and even a population of stem cells (pericytes) that are vital for healing.
Dr. Philippe Hernigou, a pioneering orthopedic surgeon from France, conducted groundbreaking research on this topic. He compared the number of reparative cells in the iliac crest bone marrow (a common site for harvesting bone marrow) with the number of cells in the subchondral bone of an osteoarthritic knee. His findings were astonishing. As osteoarthritis progressed and patients aged, the concentration of these crucial healing cells in the subchondral bone declined dramatically, whereas levels in the iliac crest remained relatively stable (Hernigou et al., 2013). This suggests that the local healing environment within the knee itself becomes depleted.
This discovery has paved the way for a new and powerful treatment strategy: intraosseous injections. By injecting orthobiologics such as PRP or BMAC directly into the subchondral bone, we can replenish the depleted cellular environment and address the “bone” component of osteoarthritis.
A recent meta-analysis and a consensus statement we published for the American Academy of PM&R have recognized that intraosseous PRP injection has significant merit, particularly for more advanced stages of knee osteoarthritis.
Perhaps the most compelling evidence comes from a pair of sister studies looking at intraosseous BMAC. In one study, patients had one knee replaced and the other treated with an intraosseous bone marrow injection. With an average follow-up of 15 years, over 80% of patients avoided a knee replacement in their treated knee. Remarkably, they overwhelmingly preferred their “bone marrow knee” to their artificial one (Hernigou et al., 2021).
The sister study involved patients who wanted to avoid surgery altogether. They received an intra-articular injection in one knee and an intraosseous injection in the other. Both knees improved, but the knee that received the intraosseous injection had a significantly lower rate of conversion to a total knee replacement (Hernigou et al., 2020).
The takeaway is clear: for severe osteoarthritis, we must look beyond the joint space and the surrounding soft tissues. We must also treat the bone. This is the essence of treating the whole functional unit.
The Art of Diagnosis: How We Decide What to Treat
So, how do we put all this together in a clinical setting? How do we decide which structures to treat? It’s not a matter of just guessing; it’s a combination of deep anatomical knowledge, a thorough physical exam, and the art of clinical reasoning.
This is where we put on our thinking caps. Let’s consider a patient with medial (inner) knee osteoarthritis.
The Exam: A physical exam might reveal a varus deformity (bow-legged stance), which places excessive stress on the medial compartment of the knee.
The Analysis: This varus stress not only compresses the medial meniscus and cartilage but also stretches and weakens structures on the lateral (outer) side of the knee, such as the lateral collateral ligament (LCL).
The Treatment Plan: A comprehensive treatment plan wouldn’t just address the medial joint space. It would also involve treating the LCL to restore stability and correct the biomechanical imbalance that is driving the degeneration.
Conversely, if a patient has a valgus moment (knock-kneed) and lateral compartment arthritis, we would assess the lateral structures as well as the medial ligaments that are being overstretched.
Or consider a case of patellofemoral pain or maltracking, where the kneecap is being pulled laterally. The solution isn’t just to treat the cartilage behind the kneecap. We must ask why it’s being pulled. Often, the medial patellofemoral ligament (MPFL), which acts as a checkrein, is weak or damaged. Treating and strengthening this ligament is key to restoring proper tracking.
Chiropractic Integration: The Bigger Biomechanical Picture
This is where integrative chiropractic care becomes indispensable. The buck doesn’t stop at the knee. We must ask: why did this atraumatic knee issue develop in the first place?
As a chiropractor, I am trained to look at the entire kinetic chain.
Look Distally: We must examine the ankle and foot mechanics. Is there excessive foot pronation causing the tibia to internally rotate, creating a valgus stress at the knee?
Look Proximally: We must evaluate the hip and gluteal muscles. One of the most critical muscles for knee (and hip) stability is the gluteus medius. Weakness in this muscle is a common driver of lower-extremity dysfunction.
Look to the Spine: Could there be a subclinical radiculopathy? A slight nerve impingement in the lumbar spine can cause weakness in key muscles, such as the EHL (the muscle that lifts the big toe), disrupting the entire gait cycle and placing abnormal stress on the knee.
In my practice, I perform detailed muscle strength testing along the kinetic chain, assess for nerve tension, and use chiropractic adjustments to restore proper alignment and nervous system function. By treating only the knee, will we achieve long-term success if the underlying hip weakness or foot dysfunction remains unaddressed? The answer is a resounding no.
By integrating precise orthobiologic injections with comprehensive chiropractic care, physical therapy, and functional medicine principles, we can address the problem from every angle. This is what I mean when I say we must treat the whole person, not just the pain generator. In doing so, we turn the problem into a “treatment generator”—an opportunity to restore health to the entire system.
This is the future of musculoskeletal medicine. It requires us to go back to our roots in anatomy, physiology, and biomechanics, but to apply that knowledge with the most advanced tools and a holistic, integrated mindset. It’s a truly fulfilling way to practice, and it offers our patients the best possible chance for a long-term, functional recovery.
References
Centeno, C. J., Markle, J., Dodson, E., Stemper, I., Williams, C. J., Kisiday, J. D., … & Steinmetz, N. J. (2017). The use of lumbar epidural injection of platelet lysate for treatment of radicular pain. Journal of Experimental Orthopaedics, 4(1), 38. https://dx.doi.org/10.1186%2Fs40634-017-0113-5
Centeno, C., M.D., Pitts, J., M.D., Al-Sayegh, H., M.D., & Freeman, M., D.C., PhD. (2020). Efficacy of autologous, micro-fragmented adipose tissue with leukocyte poor-platelet rich plasma for the treatment of knee osteoarthritis: a randomized controlled crossover study. Journal of Translational Medicine, 18(131). https://doi.org/10.1186/s12967-020-02285-3
Dudley, H. A. F., & White, J. C. (n.d.). Operative Surgery: Fundamental International Techniques.
Hernigou, P., Poignard, A., Beaujean, F., & Rouard, H. (2013). Percutaneous autologous bone-marrow grafting for nonunions. The Journal of Bone and Joint Surgery. American Volume, 87 Suppl 1(Pt 2), 896-903. https://doi.org/10.1302/0301-620X.87B1.15783
Hernigou, P., Bouthors, C., Bastard, C., Flouzat-Lachaniette, C. H., Rouard, H., & Dubory, A. (2021). Subchondral bone marrow concentrate injection is more effective than intraarticular injection in severe osteoarthritis of the knee: a 15-year-follow-up of a randomized controlled trial. International Orthopaedics, 45(2), 341-349. https://doi.org/10.1007/s00264-020-04871-3
Hernigou, P., Delattre, L., Dubory, A., & Flouzat-Lachaniette, C. H. (2020). Intra-articular injection of bone marrow concentrate is a better choice than intra-osseous injection in less advanced osteoarthritis of the knee. International Orthopaedics, 44(7), 1293-1302. https://doi.org/10.1007/s00264-020-04535-2
Uncover the role of bioidentical HRT and integrative endocrinology in achieving optimal hormonal balance and vitality.
Abstract
In this post, I walk you through a clear, evidence-based path to understanding hormone optimization and why it is foundational to whole-body health, longevity, and disease prevention. We will explore the physiological roles of key hormones — including estrogen, testosterone, progesterone, thyroid hormones, and vitamin D — and how they influence the brain, heart, bones, metabolism, mood, and pain processing. I will define the difference between treating symptoms and healing root causes, explain the lock-and-key receptor model that distinguishes bioidentical hormones from their synthetic counterparts, and debunk common myths regarding cardiovascular risk and breast cancer. You will see how gut health and the gut-brain axis modulate hormone signaling, why “normal” lab values are not always “optimal,” and how integrative chiropractic care supports the nervous system and the hypothalamic-pituitary-adrenal axis to amplify therapeutic outcomes. Drawing from modern, peer-reviewed findings and my clinical experience, including outcomes documented across my care and education platforms, I present individualized treatment strategies — from transdermal therapy to pellet implantation — and explain exactly when, how, and why each approach is used.
Root-Cause Medicine vs Band-Aid Care: Why Healing Requires Asking “Why”
For decades, I have practiced with a simple guiding principle: “The greatest medicine of all is teaching people how not to need it.” That mindset demands distinguishing treating from healing.
Treating means quieting a symptom while the underlying cause persists. Pain medication for a recurrent headache may silence the alarm without correcting dehydration, nutrient deficiencies, sleep debt, or stress physiology.
Healing requires removing the cause so the body can restore balance — like finding the pebble in the shoe rather than numbing the toe. In hormone care, that pebble is often a deficiency, receptor insensitivity, or axis dysregulation that drives seemingly unrelated symptoms.
When patients arrive on antidepressants, anxiolytics, sleep aids, and stimulants, my position is straightforward: you are not deficient in Prozac or Xanax. Those symptoms are signals of deeper dysregulation. When we correct hormone signaling and support the body’s neuroendocrine and metabolic systems, patients don’t just feel less symptomatic — they recover function, resilience, and clarity. That is healing.
Bioidentical vs Synthetic Hormones: The Lock-and-Key Physiology
Cells communicate through precision. Hormones are keys; receptors are locks. The tighter the molecular fit, the richer the downstream signaling.
Bioidentical hormones have the exact molecular structure your body produces. They fit receptors precisely, triggering entire cascades of gene transcription, enzyme activation, cellular energy production, and repair that extend far beyond stopping a hot flash or improving libido.
Synthetic hormones are structurally altered analogs. They can wedge into the lock and quiet certain symptoms, but they do not reliably initiate the full spectrum of protective responses. Worse, they can “jam” the lock, producing off-target effects and risks seen in large trials of synthetic progestins and oral conjugated estrogens, including clotting and breast cancer risk signals that differ markedly from those associated with transdermal bioidentical estradiol and natural progesterone.
From a healing perspective, injured tissue resolves with nutrients, proper signaling, and innate intelligence — not force. Restoring the body’s native hormonal environment with bioidenticals aligns with physiology and reduces unintended consequences.
The Essential Hormone Suite: What Matters and Why
Hormones are a symphony, not soloists. The following players conduct everything from mitochondrial firing to synaptic plasticity:
Testosterone: In both sexes, testosterone maintains muscle protein synthesis, mitochondrial density, dopamine tone, motivation, and vascular integrity. Clinically, optimizing testosterone often restores energy, drive, and emotional steadiness.
Estrogen: Far beyond reproduction, estrogen modulates lipid profiles, vascular dilation, glucose handling, bone turnover, and neurotransmitter production. It interacts richly with serotonin, GABA, and acetylcholine circuits that govern clarity, memory, and mood stability.
Progesterone: A natural neurosteroid and anxiolytic, progesterone supports sleep architecture via GABAergic pathways, balances the endometrium, reduces mast cell activation, and supports bone formation and neural repair.
Vitamin D (as a secosteroid hormone): Through VDR signaling, vitamin D influences immune tolerance, autoimmunity risk, bone mineralization, muscle performance, and mood regulation. Receptor sensitivity and cellular uptake impact how other hormones exert their effects.
Thyroid hormones (T4/T3): The master metronome of metabolism, thyroid hormones regulate mitochondrial biogenesis, thermogenesis, cholesterol clearance, GI motility, and brain speed. Many patients suffer “normal lab” hypothyroid symptoms due to conversion issues (T4 to T3), inflammation, or stress-axis suppression.
Every intervention we choose respects how these systems interlock.
Finding Hormonal Harmony- Video
When Hormones Drift: The Symptom Constellations I See Every Week
Hormone insufficiency can mimic anxiety disorders, hypothyroidism, chronic fatigue, and fibromyalgia. The pattern recognition is essential:
In women:
Emotional volatility with swings into irritability or sadness
Central weight gain, fluid retention, unwanted hair changes
These are not signs of “aging we must accept.” They are flags of declining signal quality across neuroendocrine axes that can be corrected with targeted care.
Estrogen’s Systemic Power: Brain, Heart, Bone, and Beyond
Declining estradiol produces widespread changes:
Brain and mood: Estrogen modulates serotonin synthesis and receptor sensitivity, supports synaptic density, and reduces neuroinflammation. Because ~80% of serotonin is produced in the gut, estradiol’s influence on mucosal integrity, motility, and microbiome ecology threads directly into mood.
Cardiovascular protection: Estrogen raises HDL, improves endothelial function, and decreases atherogenic inflammatory signaling. Early postmenopausal initiation of estrogen therapy has been associated with profound reductions in cardiovascular events when personalized and appropriately delivered (see references).
Bone remodeling: Estrogen reins in osteoclast activity and preserves trabecular architecture. After menopause, unopposed resorption accelerates — prompting bone loss and joint discomfort that often improves with physiologic replacement.
Urogenital and GI systems: Estrogen maintains urogenital mucosal thickness, reduces susceptibility to UTIs, and supports oral health and the integrity of the colonic epithelium.
In men, a portion of testosterone’s benefits derive from conversion to estradiol via aromatase. Blocking that conversion can backfire — harming bones, vessels, and cognition.
Testosterone: Vital for Both Women and Men
A compelling endocrine fact: across a lifetime, women produce more testosterone than estrogen, yet female testosterone remains underappreciated. In my clinical work and in extensive training settings for medical providers, I find this knowledge gap consistent.
Common deficiency signs in both sexes:
Afternoon energy collapse (“2 to 4 PM crash”)
Brain fog and distractibility
Sarcopenia, increased fat mass
Low mood, irritability, and anxiety
Sleep maintenance challenges
Decreased libido and diminished sense of well-being
The therapeutic aim is not masculinization for women. As Dr. Rebecca Glaser’s research shows, women thrive at levels in the low hundreds (e.g., 100–200 ng/dL), far below male optimization ranges, and nuisance effects (like faster hair growth) are manageable without inducing male traits (Glaser & Dimitrakakis, 2013).
Progesterone: The Great Balancer in Midlife
Progesterone is typically the first hormone to decline in perimenopause, creating estrogen dominance. Natural progesterone:
Balances estrogen by protecting the endometrium and normalizing bleeding patterns
Stabilizes sleep through GABA-A receptor modulation
Calms anxiety by dampening excitatory stress signals
Supports metabolism, helping counter central adiposity
Builds bone by stimulating osteoblast activity
Prevents migraines in hormonally sensitive cycles via neurovascular stability
I use oral bioidentical progesterone strategically at night to align with sleep physiology and reduce cortisol-driven restlessness.
The Gut-Brain Axis: Why Digestion Shapes Hormone Signaling
The gut-brain axis provides a bidirectional highway between microbiome metabolism, mucosal immunity, and central nervous system function. When dysbiosis and leaky gut increase endotoxin exposure, the immune system escalates TNF-alpha and IL-6, which can:
Suppress thyroid conversion (T4 to T3), slowing metabolism
Interfere with steroid receptor sensitivity, blunting hormonal “volume.”
Destabilize serotonin and GABA tone, worsening anxiety and insomnia
Elevate cortisol, skewing glucose handling and fat distribution
Because hormones ride on the integrity of these networks, I routinely assess and address gut ecology — supporting barrier function, microbial balance, and nutrient repletion — to improve hormone outcomes.
Debunking Myths: Sex Hormones, Heart Disease, and Breast Cancer
Fear-mongering around hormones has caused avoidable suffering. Evidence clarifies:
Heart disease reality: Cardiovascular disease causes far more deaths in women than breast cancer, especially after estradiol declines. Early, individualized estrogen therapy is associated with significantly reduced cardiac events when delivered as transdermal bioidentical estradiol and combined with natural progesterone if the uterus is intact (Manson et al., 2013; NAMS, 2017).
WHI interpretation: The increased breast signal in the WHI was tied to synthetic progestin (medroxyprogesterone acetate), not natural progesterone. The Premarin-only arm showed reduced breast cancer incidence in some analyses; clotting risks were linked to oral administration, not transdermal routes. Modern, bioidentical protocols differ materially from those older findings.
Testosterone’s cardiometabolic protection: Hundreds of studies support testosterone’s role in vascular health, insulin sensitivity, lipid balance, and mood. Some benefits reflect physiologic aromatization to estradiol. Routine estrogen blockade with testosterone therapy risks heart, bone, and brain health.
The narrative that “hormones cause breast cancer” is reductive. The real drivers include chronic inflammation, hyperinsulinemia, and toxic exposures. Optimizing hormones within a comprehensive anti-inflammatory and metabolic framework reduces the risk terrain.
Bone and Brain: Hormones as Structural and Cognitive Protectors
Bone health: Estrogen and testosterone have synergistic effects — estrogen restrains resorption; testosterone promotes muscle strength and mechanotransduction, stimulating bone formation. Unlike some antiresorptives that create dense but brittle bone, physiologic hormone restoration improves bone quality, reducing fracture risk when combined with vitamin D, calcium, and resistance training.
Brain health:
Estrogen exhibits anti-inflammatory and immunomodulatory properties; the brain’s local synthesis of estradiol after injury reflects an innate neuroprotective strategy. Timed delivery of natural estradiol has shown dramatic post-ischemic benefits in experimental contexts.
Testosterone supports memory, motivation, and synaptic stability; low levels correlate with depression, increased beta-amyloid deposition, cardiometabolic risk, and higher all-cause mortality.
Pain processing: Both hormones modulate central and peripheral nociceptive pathways. In chronic pain, especially in the context of opioid use, testosterone drops precipitously, compounding pain sensitivity and slowing tissue repair. Optimizing sex hormones often reduces pain perception and accelerates recovery.
Treatment Modalities: How We Choose What to Use and Why
Personalized therapy means aligning the route, dose, and timing to your physiology and preferences.
Oral bioidenticals:
Progesterone at night synergizes with sleep architecture and GABAergic calming.
Estradiol can be oral for some, but I prefer transdermal for clot risk mitigation.
Sublingual testosterone is an option in select cases; we avoid oral synthetic testosterone due to liver and lipid concerns.
Transdermal creams and patches:
Estradiol patches deliver steady levels and circumvent first-pass hepatic metabolism, reducing clot risk and improving cardiovascular safety profiles.
Creams can work well; absorption is increased in the genital dermis due to vascularity and a thin epithelium, thereby improving pharmacokinetics.
Injections:
Effective for testosterone but can cause peaks and troughs, increasing side effects.
I avoid routine aromatase inhibitors because blocking estradiol harms joint, bone, heart, and brain health.
Pellet therapy (bioidentical):
Tiny implants placed in subcutaneous gluteal fat deliver steady, cardiac-output-modulated release for months.
Advantages include consistency, convenience, and individualized dosing without weekly fluctuations.
In my clinics, we have safely performed tens of thousands of pellet procedures, achieving robust outcomes in energy, mood, body composition, and relationships.
We select a route based on your clot risk, liver status, absorption patterns, lifestyle, and therapeutic goals, and we adjust iteratively with labs and symptom tracking to reach optimal — not merely normal — levels.
Integrative Chiropractic Care: Optimizing the Neuroendocrine Highway
As a DC and FNP, I integrate chiropractic care because the nervous system is the master regulator of the endocrine system. The spine houses the neural pathways that connect the hypothalamus, pituitary, adrenals, thyroid, gonads, and peripheral tissues.
Neurological optimization: Spinal misalignments (subluxations) can impede afferent and efferent signaling, disrupting the feedback loops that maintain hormonal balance. Targeted adjustments restore neural conduction and autonomic tone, improving endocrine responsiveness.
Stress physiology: Adjustments help downregulate sympathetic overdrive and normalize HPA-axis function, lowering chronic cortisol elevations that suppress thyroid conversion, disrupt sex hormone balance, and promote visceral adiposity.
Whole-system synergy: I assess posture, biomechanics, and neural patterns alongside labs and symptoms. When the “power is on,” hormonal signals transmit efficiently — enhancing the impact of bioidentical therapy, gut repair, and nutrient protocols.
This integrative model accelerates outcomes and deepens durability.
Clinical Observations: Real-World Outcomes and Why They Matter
“Gas in the tank” but no ignition: An 18-year-old with high-normal testosterone (~1,000 ng/dL) presented with depression, anxiety, and poor focus. The issue was not production; it was receptor sensitivity. By supporting vitamin D (for VDR and steroid receptor modulation), iodine (for thyroid support), and methylated B vitamins (for methylation and neurotransmitter pathways), his symptoms resolved rapidly. He discontinued psychiatric medications and regained function. This underscores that hormones require cofactors and competent receptors to work.
“Getting her life back at 65”: After synthetic hormones were stopped at age 60 per outdated rules, a patient developed severe depression and withdrawal. Bioidentical pellet therapy restored estradiol, progesterone, and testosterone, and she experienced profound mood and relationship recovery. Her story is emblematic of the shift away from “lowest dose for shortest time” toward individualized, evidence-based longevity care (NAMS, 2017).
My clinical platforms consistently document these transformations across energy, cognition, mood, pain, and relationships, validating the integrated approach.
Why “Normal” Is Not Always “Optimal”
Population-based reference ranges reflect averages — not targets for vitality. Example: a vitamin D level of 35 ng/mL may be “normal,” yet evidence aligns disease prevention and immune optimization with levels typically above 60 ng/mL when individualized and monitored. Similarly, thyroid and testosterone “normalcies” might leave patients foggy, unmotivated, and fatigued.
We test, treat, and retest — using symptom resolution, functional metrics, and lab optimization to find your personalized sweet spot.
The goal is not “not sick.” The goal is vibrant.
Putting It All Together: A Practical, Personalized Pathway
Every plan is individualized, but the strategy follows clear physiology:
Assess and align:
Detailed history of symptoms, stress, sleep, nutrition, and gut health
Comprehensive labs: sex hormones, thyroid panel (with free T3), vitamin D, metabolic markers, inflammatory cytokines as indicated
Chiropractic adjustments to normalize neural signaling and HPA-axis tone
Lifestyle programming: resistance training for bone and insulin sensitivity, sleep optimization for hormone rhythm, stress practices for cortisol control
Monitor and refine:
Follow-up labs and symptom maps
Dose adjustments to maintain physiologic ranges and minimize side effects
Ongoing education so you understand the “why” behind each change
This is how we move from treating to healing.
Key Takeaways For Your Health Journey
Hormone imbalances can occur at any age, affecting mood, energy, muscle function, cognition, and relationships.
Bioidentical hormones fit receptor locks precisely, unlocking protective cascades in brain, heart, bone, and metabolism.
Transdermal estradiol and natural progesterone differ materially from older synthetic regimens, shifting risk profiles and outcomes.
Testosterone is vital for women and men; blocking estrogen in men is typically harmful.
Gut health and the nervous system set the stage for hormone signaling; repair and alignment amplify results.
Normal is not optimal; personalization is essential for long-term vitality.
Integrative chiropractic care enhances neuroendocrine transmission and stress-axis regulation, increasing the efficacy of hormone therapy.
You do not have to live in a fog of fatigue, irritability, and disconnection. With modern, evidence-based, integrative care, you can reclaim clarity, purpose, and a vibrant life.
In the ever-evolving landscape of regenerative medicine, platelet-rich plasma (PRP) has emerged as a cornerstone therapy for a multitude of musculoskeletal conditions, most notably osteoarthritis. However, the clinical conversation is shifting from a simple “yes or no” regarding its use to a more sophisticated understanding of “how” and “why” it works. This post will take you on an educational journey into the nuanced world of PRP therapy. We will explore the critical concepts of platelet concentration, the evolving debate over leukocyte ratios (leukocyte-rich vs. leukocyte-poor PRP), and the latest evidence-based findings reshaping our treatment protocols. Drawing upon modern research and my clinical observations, we will demystify the physiological mechanisms at play, explaining how we can optimize treatments by focusing on absolute platelet dosage and understanding the synergistic roles of different cell types. Furthermore, we will connect these advanced regenerative techniques to the foundational principles of integrative chiropractic care, illustrating how a comprehensive approach that addresses biomechanical integrity and systemic health is paramount for achieving lasting patient outcomes.
The Evolution of PRP: Beyond Leukocyte Ratios to Precise Dosing
For years, the regenerative medicine community has engaged in a robust discussion about the ideal formulation of PRP. A central point of this debate was the white blood cell (leukocyte) ratio in the PRP preparation. This led to the common classification of PRP into leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) subtypes. The prevailing thought was that one type might be superior for specific conditions—for instance, that the pro-inflammatory nature of leukocytes in LR-PRP could be detrimental for an already inflamed arthritic joint.
This classification system, born around 2011-2012, was a significant step forward. It gave us a framework to begin conceptualizing and comparing different PRP preparations. It was a way for clinicians like myself to ask, “What is our patient actually receiving?” However, as science progresses, so must our understanding.
A Paradigm Shift in Understanding
Recent research has begun to challenge this dichotomous view. In a fascinating turn, some of the very same researchers who first proposed the importance of leukocyte ratios published a pivotal paper around 2022. Their updated findings, specifically regarding joint arthritis, suggested that, in the long run, the distinction between leukocyte-rich and leukocyte-poor PRP may not be as critical as we once believed (Le et al., 2022).
This finding aligns with a growing body of evidence that points to a different, perhaps more crucial, variable: the absolute platelet dose. Instead of focusing solely on the cell ratio, the focus is shifting to the total number of platelets delivered to the target tissue. The question is evolving from “Is it rich or poor in leukocytes?” to “How many billion platelets are we administering?” This represents a significant paradigm shift, moving us toward a more precise, dose-dependent approach to regenerative therapy.
In my own practice, I’ve observed this principle in action. A recent case involved a patient for whom we prepared PRP with a concentration factor of approximately 7.5 times their baseline platelet count. While this number can vary from patient to patient due to individual physiology, our advanced processing systems consistently yield concentrations in the 6x-10x range. The key was not just the concentration but the processing method, which allowed us to capture a high platelet yield, ensuring we delivered a therapeutically significant dose.
The Intricate Cellular Symphony Within PRP
To truly appreciate the power of PRP, we must look at the intricate components of the preparation and how they work together. Using modern separation systems, we can meticulously isolate different fractions of the blood.
Understanding the Buffy Coat and Its Components
When blood is centrifuged, it separates into three main layers:
Red Blood Cells (Erythrocytes): The dense bottom layer.
Platelet-Poor Plasma (PPP): The clear, liquid top layer.
The Buffy Coat: A thin, whitish layer sandwiched between the other two.
The buffy coat is the treasure trove of regenerative medicine. It is densely packed with platelets and most leukocytes. The historical fear was the inclusion of the reddish layer just below the buffy coat, as it was thought to contain pro-inflammatory cells that could worsen conditions like arthritis.
However, our understanding of these cells has become much more refined. Advanced analysis reveals that this reddish zone, while containing some red blood cells, is also rich in specific leukocyte types, namely lymphocytes and monocytes. Far from being purely detrimental, these cells play a vital, beneficial role in the healing cascade.
Monocytes are particularly fascinating. When introduced to an injury site, they can differentiate into macrophages, which are essential for clearing cellular debris. More importantly, they help orchestrate the subsequent regenerative phases. The presence of lymphocytes helps guide these monocytes toward a pro-regenerative (M2) phenotype rather than a pro-inflammatory (M1) one.
This means that a PRP preparation that strategically includes these cell populations can create a more robust and sophisticated healing signal. The lymphocytes and monocytes don’t just add to the inflammation; they help manage it and then initiate a structured, beneficial healing response. This is why the conversation is moving away from simply labeling PRP as “leukocyte-rich.” It’s about understanding which leukocytes are present and their specific functions. The granulocytes (like neutrophils), which are more associated with acute inflammation, are largely separated out, while the beneficial monocytes and lymphocytes are retained.
This new perspective helps explain a retrospective observation: systems that produced “leukocyte-rich” PRP often happened to capture more platelets. The superior outcomes seen in some studies using LR-PRP for tendon injuries, for example, may have been less about the leukocytes and more about the higher absolute platelet dose being delivered (Filardo et al., 2018).
The Crucial Role of Integrative Chiropractic Care
Advanced regenerative treatments like PRP are powerful tools, but they do not exist in a vacuum. To achieve the best possible outcomes, we must address the entire patient, including the underlying biomechanical and structural issues that contributed to the injury or degeneration in the first place. This is where integrative chiropractic care becomes an indispensable partner to regenerative medicine.
Imagine injecting a highly potent, regenerative PRP preparation into a knee joint that is suffering from osteoarthritis. If that knee remains misaligned, with improper patellar tracking and imbalanced forces from dysfunctional muscles in the hip and ankle, the regenerative therapy is fighting an uphill battle. The very same pathological forces that wore down the cartilage remain, poised to degrade the newly formed tissue.
Creating an Optimal Healing Environment
As a chiropractor and functional medicine practitioner, my approach is to create an optimal environment for these regenerative cells to do their work. This involves a multi-faceted strategy:
Biomechanical Correction: Through precise chiropractic adjustments, we restore proper joint alignment not just in the affected joint but along the entire kinetic chain. For a knee issue, this means assessing and correcting imbalances in the spine, pelvis, hips, and ankles. This ensures that forces are distributed evenly, reducing pathological stress on the healing tissues.
Myofascial Release and Rehabilitation: We use advanced soft-tissue techniques to release adhesions, correct muscle imbalances, and restore proper function. This might involve active release techniques, instrument-assisted soft tissue mobilization, and targeted therapeutic exercises. This step is crucial for ensuring the joint is supported by a strong, balanced, and functional muscular system.
Nutritional and Metabolic Support: Healing is a metabolically demanding process. Through a functional medicine lens, we assess and optimize the patient’s nutritional status. This includes ensuring adequate levels of key vitamins and minerals (like Vitamin C, Zinc, and Magnesium) and managing systemic inflammation through diet and targeted supplementation (e.g., omega-3 fatty acids, curcumin). A systemically inflamed body will have a blunted response to any localized regenerative therapy.
By integrating these approaches, we are not just treating the site of pain; we are re-establishing the foundation for health. The chiropractic adjustments and physical rehabilitation prepare the “soil” by correcting the biomechanical environment, while the PRP injection acts as the “seed,” providing the cellular machinery for growth and repair. This comprehensive model significantly enhances the potential for long-term success and is a core tenet of my clinical philosophy at Injury Medical & Chiropractic Clinic.
A New Frontier in Regenerative Orthopedics
We stand at an exciting new frontier in the treatment of musculoskeletal conditions. The science of PRP is moving beyond simplistic classifications and toward a more sophisticated, evidence-based approach centered on precise dosing and a deeper understanding of cellular interactions. The latest research from leading experts is guiding us to optimize our methods, not by eliminating certain cells, but by understanding how to harness their synergistic potential to orchestrate a powerful healing response.
For patients suffering from conditions like joint arthritis, this means more effective and reliable outcomes. By combining these cutting-edge regenerative therapies with the foundational principles of integrative chiropractic care, we can address both the symptoms and the root cause of their condition. This holistic approach ensures that we are not only repairing damaged tissue but also restoring function, improving biomechanics, and empowering the body’s innate capacity to heal itself, resulting in lasting relief and improved quality of life.
References
Filardo, G., Di Matteo, B., Kon, E., Merli, G., & Marcacci, M. (2018). Platelet-rich plasma in tendon-related disorders: results and indications. Knee Surgery, Sports Traumatology, Arthroscopy, 26(7), 1984–1999. https://doi.org/10.1007/s00167-016-4261-4
Le, A. D. K., Enweze, L., DeBaun, M. R., & Dragoo, J. L. (2022). Current clinical recommendations for use of platelet-rich plasma. Current Reviews in Musculoskeletal Medicine, 15(6), 442–453. https://doi.org/10.1007/s12178-022-09787-z
In this educational post, I walk you through a clear, evidence-based journey into hip osteoarthritis (hip OA): what it is, how it affects health, why it hurts, and what we can do about it using modern, research-backed strategies. I integrate my clinical observations and multidisciplinary approach as Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, to explain the anatomy of the hip, common pain patterns, examination methods, and current treatment options—from physical therapy and integrative chiropractic care to corticosteroid injections and platelet-rich plasma (PRP). I also present emerging data from leading researchers, compare outcomes across treatments, and detail a patient case that shows how precise diagnosis and thoughtful biomechanics-centered therapy can restore function and reduce pain. Finally, I offer practical protocols, physiological explanations, and the rationale behind each intervention so you know how and why these strategies work and when they are most effective.
Understanding Hip Osteoarthritis: Global Burden, Risk, and Mortality
As a family-trained clinician and integrative practitioner, I have seen hip OA evolve from a “common musculoskeletal complaint” into a global health concern with measurable impacts on mortality and quality of life. The data paint a compelling picture.
Between 1990 and 2019, the number of hip OA cases worldwide rose from approximately 740,000 to 1.6 million, reflecting an expanding global burden and consistent incidence growth across most regions.
High-income nations, especially in North America, show higher incidence and prevalence—a pattern likely driven by activity profiles, aging demographics, metabolic health, and diagnostic capture rates.
The disability-adjusted life years (DALYs) for hip OA continue to increase, emphasizing the condition’s meaningful impact on daily function and long-term health.
The physiological story behind these numbers is clear: symptomatic hip OA reduces physical activity, and reduced activity is tied to higher age-adjusted mortality. In large cohorts, hip OA has been associated with increased all-cause mortality (about 14%) and cardiovascular mortality (about 24%). These associations are not just correlations; they speak to a cycle where pain leads to inactivity, inactivity drives metabolic dysregulation, and systemic health declines follow.
Why this matters in the clinic: when you treat hip OA, you aren’t only treating pain—you are intervening on function, metabolic health, and longevity. Any successful plan must intelligently restore movement, reduce inflammation, and rebuild resilient biomechanics.
Hip Anatomy and Pain Patterns: Why Location Matters
To treat hip OA well, we need to understand the structure and the story it tells.
The hip is a ball-and-socket joint—the femoral head articulates with the acetabulum of the pelvis, stabilized by labrum, ligaments, and a powerful muscular envelope.
Key bony landmarks include the acetabulum, femoral neck, greater trochanter (gluteal tendon insertions), and sacroiliac (SI) joint—a crucial stabilizer in pelvic load transfer.
The region is rich in neurovascular and muscular structures, any of which can mimic or compound joint-origin pain.
Patients commonly describe:
Anterior hip and groin pain: classically hip joint–origin, often a C-shaped distribution wrapping the groin.
Lateral hip pain: more often greater trochanteric pain syndrome or gluteal tendinopathy.
Posterior hip/buttock pain: can arise from the SI joint, piriformis, hamstring origin, or referred lumbar sources—but up to 10% of true hip joint pathology can also present posteriorly.
Synovial inflammation (synovitis) increases pain mediators and joint effusion.
Biomechanical maldistribution—caused by weakness or altered motor control—overloads focal cartilage zones, accelerating wear and increasing pain.
Clinical takeaway: pain location guides initial hypotheses, but do not anchor prematurely—hip joint pathology can masquerade. If posterior pain persists despite typical SI or hamstring care, look deeper into the hip joint.
Hip Examination: Functional Findings That Guide Accurate Diagnosis
A thorough hip exam identifies motion deficits, reproduces joint-specific pain, and distinguishes hip-origin pain from adjacent structures.
Key elements I rely on:
Range of Motion: Internal and external rotation are highly informative. A reduction in internal rotation is characteristic of hip OA due to capsular fibrosis and osteophyte impingement.
Log Roll Test: Passive rolling of the leg identifies intra-articular irritability and capsular sensitivity.
Straight Leg Raise: Useful primarily for lumbar radicular patterns—helps differentiate hip from spine.
FABER (Flexion, ABduction, External Rotation): Reproduces hip joint or SI joint pain depending on localization. I always ask patients to pinpoint the location of the pain during this test.
FADIR (Flexion, ADduction, Internal Rotation): Often the most sensitive maneuver for intra-articular hip pathology, including OA and femoroacetabular impingement.
Physiological reasoning:
These maneuvers compress or tension specific regions of the hip capsule and labrum, eliciting pain from mechanoreceptors and nociceptors when pathology is present.
Motion restriction is frequently driven by capsular contracture, osteophytes, and intra-articular debris and is mirrored by predictable deficits in rotation.
Why Physical Therapy and Integrative Chiropractic Care Are Foundational
No injection or surgical tool can outrun poor biomechanics. My approach always begins with restoring movement capacity and load tolerance across the hip-pelvis-lumbar complex. This is where integrative chiropractic care shines alongside physical therapy.
What we aim to correct:
Pelvic alignment and SI joint stability: misalignment or instability amplifies shear forces into the hip.
Gluteal strength and timing: the gluteus medius/minimus stabilize frontal-plane load; deficits increase compressive stress on the joint and greater trochanter.
Core integration: a well-coordinated deep core (diaphragm, pelvic floor, transversus abdominis, multifidus) reduces axial load on the hip and improves lumbopelvic rhythm.
Hip mobility: safe restoration of internal rotation and extension enables proper gait mechanics and reduces anterior joint stress.
How integrative chiropractic care fits:
High-velocity, low-amplitude (HVLA) adjustments for the SI joint and lumbar segments can restore segmental motion and reduce neurogenic guarding.
Low-force mobilizations and instrument-assisted soft tissue techniques for the gluteal fascia, tensor fasciae latae, and iliopsoas reduce myofascial loading and pain.
Neuromuscular re-education and movement retraining align joint mechanics with muscular effort—this is where chiropractic clinical reasoning complements PT exercise progression.
Improved alignment and neuromuscular timing reduce aberrant shear, compressive hotspots, and inflammatory signaling within the joint capsule.
Effective core-gluteal integration redistributes load across tissues adapted to force absorption, reducing stress on compromised cartilage.
Restored motion reduces synovial stagnation, enhancing nutrient diffusion and clearance of inflammatory byproducts.
My clinical observations:
Patients who commit to combined PT plus integrative chiropractic protocols progress more consistently, with fewer flares and better long-term function. In complex or athletic cases, this joint strategy is often the difference between symptom reduction and meaningful restoration of performance (Jimenez, n.d.-a; Jimenez, n.d.-b).
Corticosteroid injections into the hip joint are a longstanding tool for pain modulation and diagnostic clarity.
What the evidence shows:
Randomized trials indicate significant pain relief at approximately 3 months compared with saline or placebo, but benefits often diminish by 6 months.
Major societies, including the American Academy of Orthopaedic Surgeons, offer moderate-strength recommendations for use focused on short-term pain reduction and for diagnostic purposes.
Physiological rationale:
Corticosteroids suppress synovial inflammation by inhibiting phospholipase A2 and downstream eicosanoid pathways, thereby reducing prostaglandin and leukotriene production.
I use a targeted diagnostic injection when the pain generator is unclear (hip vs. SI vs. lumbar vs. trochanteric tendinopathy). If pain transiently resolves after an intra-articular injection, it helps confirm that the symptoms originate from the hip joint.
In patients needing rapid symptom control to engage in rehabilitation, a single injection can jumpstart movement restoration, but it must be paired with biomechanics-focused care. Without strengthening and mobility retraining, benefits fade and may not alter the disease trajectory.
Platelet-Rich Plasma (PRP): Longer-Lasting Relief and Biological Repair Signals
PRP has emerged as a biologic option for hip OA with growing support from randomized controlled trials. While protocols vary, several consistent findings guide clinical practice.
Key insights from pooled studies:
Across multiple randomized controlled trials, PRP reduces pain at several time points, with low- to moderate-quality evidence supporting clinically meaningful improvements over 3–6 months.
Single-injection protocols often perform as well or better than series protocols, possibly due to reduced post-injection flares and more precise dosing.
Lower volumes are associated with better outcomes and fewer adverse events. In practice, volumes of 3–6 mL are well tolerated; large-volume injections (≥15 mL) increase discomfort without clear benefit.
Why PRP works physiologically:
PRP concentrates platelets and growth factors (e.g., PDGF, TGF-β, VEGF, IGF-1), which can modulate inflammation, enhance matrix synthesis, and support chondral homeostasis.
Leukocyte-poor PRP in joints may reduce levels of catabolic cytokines (IL-1β, TNF-α) more effectively than leukocyte-rich formulations, thereby decreasing synovial irritation.
Rebalancing the joint environment helps calm nociceptive signaling and may slow degenerative cascades.
Comparative outcomes:
Systematic reviews comparing corticosteroids, hyaluronic acid, and PRP frequently show PRP achieving the lowest pain scores at 6 months, while steroids offer earlier relief with shorter durability.
The conclusion: use steroids for diagnostic and short-term flare control, and consider PRP for medium-term pain reduction and functional gains—always coupled with integrative rehabilitation strategies.
Protocol design:
I favor single, ultrasound-guided intra-articular injections of leukocyte-poor PRP in the 3–6 mL range.
Post-procedure, I avoid NSAIDs for 5–7 days to preserve platelet signaling, focusing on a gentle range of motion, progressive strength work, and neuromotor retraining as pain allows.
Based on patient response and goals, repeat injections can be considered at 4–6 months, though many patients do well with a single carefully designed protocol.
Case Study: When Hip OA Masquerades as Spine Pain
I want to share a case that exemplifies how careful diagnosis and integrative care change outcomes.
A 22-year-old college linebacker transferred into our program with a 6-month history of “low back pain.” He had undergone multiple epidural steroid injections, medial branch blocks, and sciatic injections with no lasting benefit.
On exam, his hip internal rotation was limited to about 15 degrees, and FABER reproduced deep anterior pain. Lumbar spine imaging showed an L5-S1 disc herniation—consistent with prior studies—but it did not explain his persistent pain patterns.
Focused hip imaging revealed cortical irregularity near the femoral head-neck junction, suggestive of intra-articular pathology.
Our plan:
Begin PT focused on core and gluteal strengthening with controlled restoration of hip mobility.
Perform a diagnostic intra-articular injection—his pain resolved, confirming hip joint origin.
Follow with a PRP injection during the off-season (about three and a half months later), coupled with progressive biomechanics work.
Outcome:
He completed the next three years without lost time due to hip or lumbar complaints. The take-home point: accurate identification of the pain generator and integration of chiro-PT protocols enable biologics such as PRP to deliver meaningful, durable relief.
Building a Comprehensive Hip OA Treatment Plan: Step-by-Step
Here is how I structure care for hip OA patients, grounded in physiology and research:
Assessment and Differential:
Clarify pain location: anterior (intra-articular), lateral (gluteal/trochanteric), posterior (SI/lumbar—but keep hip in mind).
Encourage consistent moderate physical activity to counteract the inactivity–mortality link.
Support metabolic health with anti-inflammatory nutrition and sleep strategies; metabolic syndrome worsens OA outcomes.
Why this works:
The combination of reduced inflammation (steroids or PRP) and restored biomechanics (PT and chiropractic) interrupts the pain–inactivity cycle.
Over time, patients build tissue tolerance, restore joint motion, and regain confidence in movement—crucial for maintaining function and preventing relapse.
Biologics in Hip OA: Dosing, Volume, and Future Directions
Key open questions—and how we navigate them now:
Optimal platelet dose: Current evidence suggests benefit from leukocyte-poor formulations; higher platelet counts might aid repair signaling, but must be balanced against synovial reactivity.
Volume considerations: Clinical observations and pooled data indicate that lower volumes (3–6 mL) improve comfort and outcomes compared with higher volumes. Larger volumes can elevate intra-articular pressure and irritate the joint.
Frequency: Several analyses favor single-injection strategies, possibly due to reduced cumulative synovial irritation.
Concentrated plasma: Novel systems aim to enrich anti-inflammatory and anti-degenerative proteins while minimizing leukocytes—promising in theory, but we need standardized reporting and head-to-head trials to establish superiority.
From bench to bedside:
Biologic therapies target the catabolic milieu of OA—reducing inflammatory cytokines, encouraging matrix maintenance, and supporting chondrocyte survival. The best outcomes occur when biologics are a bridge to better mechanics, not a stand-alone fix.
Practical Protocol: My Clinic Approach to PRP for Hip OA
Here is a simplified overview of how I implement PRP:
Patient Selection:
Symptomatic hip OA with functional limitations despite conservative care.
No active infection, coagulopathy, or uncontrolled systemic inflammation.
Preparation:
Use a benchtop processing system to obtain leukocyte-poor PRP.
Target 3–6 mL intra-articular injection volume.
Procedure:
Ultrasound-guided injection for precision and safety.
Post-procedure, avoid NSAIDs for 5–7 days; consider acetaminophen for discomfort.
Rehabilitation:
Initiate gentle ROM within 24–72 hours, as tolerated.
Progress gluteal/core strengthening, balance, and hip control drills.
Incorporate chiropractic mobilization for SI/lumbar segments as needed to normalize load transfer.
Follow-Up:
Reassess function and pain at 6–8 weeks and 3–6 months.
Consider repeat PRP at 4–6 months if pain/function plateaus and patient goals demand.
Physiological reasoning:
This cadence respects platelet signaling timelines, reduces synovial irritation, and uses the post-injection window to re-pattern movement for lasting benefit.
Clinical Pearls and Red Flags
If posterior hip pain persists after targeted SI/piriformis/hamstring care, suspect intra-articular hip pathology—retest with FADIR and guided imaging.
Loss of internal rotation is a small but potent predictor of hip joint involvement.
Avoid chasing pain with serial injections without improving mechanics—the hip demands a systems approach.
Encourage consistent activity—the mortality data are a reminder that movement is medicine.
Conclusion: A Modern Framework for Hip OA That Puts Biomechanics First
Hip OA is more than cartilage loss—it is a dynamic interplay between inflammation, mechanics, and behavior. The latest research consistently shows:
Corticosteroids provide short-term relief and diagnostic help.
PRP offers more durable pain reduction at 6 months for many patients.
The best outcomes come when we pair biologics with integrative chiropractic care and targeted physical therapy to restore motion, stability, and confidence.
In my practice, this combined approach delivers meaningful improvements in pain and function, supports systemic health through increased activity, and respects the hip’s complexity. When we treat the hip as both a joint and a node in a kinetic chain, we change lives—not just symptoms.
Explore the role of PRP therapy in sports medicine in speeding up recovery and supporting athletes in peak condition.
PRP and Protein Concentrate Therapy
As a clinician deeply invested in integrative medicine, I, Dr. Alexander Jimenez, am constantly exploring innovative, evidence-based therapies to enhance patient outcomes. My work across various disciplines—including as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), and Board-Certified Family Nurse Practitioner (FNP-BC)—has shown me the profound need for comprehensive treatment strategies. Today, I want to share insights into a powerful combination therapy that is changing the landscape of sports medicine and regenerative care: Platelet-Rich Plasma (PRP) enhanced with Protein Concentrate (PC). This approach represents a significant step forward, offering more than just temporary relief by addressing the underlying biochemical environment of an injury. We will delve into the science, explore the clinical applications, and discuss how this therapy, when integrated with chiropractic care and structured rehabilitation, can create superior, long-lasting results for our patients.
Abstract: Enhancing Regenerative Outcomes
This post explores the synergistic use of Platelet-Rich Plasma (PRP) and Protein Concentrate (PC) in managing musculoskeletal conditions. We will begin by defining Protein Concentrate, a derivative of platelet-poor plasma, and detailing its key anti-inflammatory and regenerative components, such as Alpha-2-Macroglobulin (A2M) and various growth factors. I will present the scientific rationale for combining these therapies, highlighting how the anti-catabolic properties of PC complement the anabolic effects of PRP. We will examine compelling research, including a pivotal study demonstrating long-term benefits for knee osteoarthritis, and discuss how to apply these findings in a clinical setting. This educational journey will cover patient selection, specific injection protocols for joints such as the knee and shoulder, and the critical role of data collection in refining our practice. Finally, I will explain how this advanced regenerative approach integrates seamlessly with a comprehensive care model that includes chiropractic adjustments, targeted rehabilitation, and other modalities to optimize healing and differentiate a practice within the competitive healthcare landscape.
Understanding Protein Concentrate: The Other Half of the Equation
In my practice, I frequently use Platelet-Rich Plasma (PRP), a therapy well-known for its healing properties. PRP is derived from a patient’s own blood and contains a high concentration of platelets, which release growth factors that stimulate tissue repair. But what about the other part of the blood that is separated during this process—the platelet-poor plasma (PPP)? For a long time, this component was often discarded. However, leading researchers have shown us that PPP is a treasure trove of beneficial molecules. When we run platelet-poor plasma through a specialized filtration system, we obtain what is known as Protein Concentrate (PC). This process isolates and concentrates powerful proteins that play a crucial role in modulating the joint environment.
Key Components of Protein Concentrate
So, what makes Protein Concentrate so valuable? It’s all about its molecular makeup. The key players include: Alpha-2-Macroglobulin (A2M): This is the star of the show. A2M is a very large protein (around 720 kilodaltons) that acts as a powerful protease inhibitor. In an inflamed or arthritic joint, destructive enzymes called proteases are overactive, breaking down cartilage and perpetuating a cycle of degradation and pain. When injected into a joint, A2M acts like a molecular trap, irreversibly binding to these proteases and neutralizing their destructive activity. This has a profound anti-catabolic effect, essentially stopping the breakdown process in its tracks. Interleukin-1 Receptor Antagonist (IL-1Ra): Interleukin-1 (IL-1) is a potent inflammatory cytokine that drives pain, swelling, and cartilage degradation in conditions like osteoarthritis. PC is rich in IL-1Ra, a naturally occurring protein that blocks IL-1 receptor signaling. By preventing IL-1 from binding to its receptor, IL-1Ra effectively shuts down this major inflammatory pathway, leading to significant symptom relief. Growth Factors: While PRP is the primary source of growth factors, PC also contains beneficial ones, including: Vascular Endothelial Growth Factor (VEGF): Promotes the formation of new blood vessels, which is essential for delivering nutrients and oxygen to healing tissues. Epidermal Growth Factor (EGF): Stimulates our own adult mesenchymal stem cells, encouraging them to participate in the repair process. Platelet-Derived Growth Factor (PDGF-BB): Another powerful stimulant for mesenchymal stem cell activity. By combining the anabolic (tissue-building) signals from PRP with the anti-catabolic (breakdown-blocking) and anti-inflammatory power of PC, we create a much more comprehensive and synergistic treatment environment within the joint.
The Clinical & Economic Case for Combining PRP and Protein Concentrate
In today’s healthcare market, especially for cash-based services like regenerative medicine, it’s not enough to offer a standard treatment. Patients are discerning; they want the best possible outcomes and are willing to invest in treatments that provide superior, lasting value. This is where offering a combination of PRP and Protein Concentrate becomes a powerful practice differentiator. Think of it in terms of a “good, better, best” model: Good: A standard PRP injection. This is effective and offered by many practitioners. Better/Best: A combined PRP + PC injection. This premium service is justified by its enhanced mechanism of action—it doesn’t just stimulate repair; it actively protects the joint from further damage. This provides faster comfort, improved longevity, and a stronger rationale for a premium price point. From my clinical observations, patients who opt for the combined therapy often experience more rapid pain relief and a more durable outcome. When we further stack the deck in the patient’s favor by integrating this with a full rehabilitation program—including chiropractic care, laser therapy, or shockwave therapy—we create a system designed for success. As a practitioner, this allows you to build a reputation on superior results, the ultimate differentiator. The economics are also compelling. While adding PC to a PRP procedure increases the patient’s fee, the incremental cost of goods for the PC filter is relatively low. This results in a significantly higher profit margin for the procedure, allowing a practice to thrive while delivering a top-tier service.
Sports Injury Rehabilitation- Video
Evidence-Based Success: Long-Term Results for Knee Osteoarthritis
We must ground our clinical decisions in solid evidence. One of the most compelling pieces of research in this area comes from a 2017 paper by M.S. Mautner, K., & Colberg, R. E. (2017). They conducted a study on 82 knees with moderate-to-severe (Grades II, III, and IV) osteoarthritis. These were not “cherry-picked” easy cases; they represented the real-world challenges we see in our clinics. The patients were treated with what the study termed “autologous protein solution,” which is essentially the Protein Concentrate we are discussing. The results were remarkable: Patients showed statistically significant improvements in pain and function at three months. Most impressively, these positive results were sustained for up to three years after a single injection. This is a game-changer. We know from other research, such as Mei-Dan et al. (2012), that the benefits of PRP alone for knee osteoarthritis typically last around 12 to 18 months. The Mautner study suggests that adding the anti-catabolic and anti-inflammatory power of PC can potentially double the duration of effect. This provides immense value to the patient, who is looking for a long-term solution, not just a temporary fix. While the best results were seen in patients with Grade II and III osteoarthritis, even those with “bone-on-bone” Grade IV arthritis saw benefits. Of course, science is never unanimous. Other studies have shown more mixed results, and it’s our responsibility as clinicians to present a balanced view. Transparency builds trust. I tell my patients that while the evidence is strong and my clinical experience is positive, no single therapy is a cure-all. This honest, evidence-informed approach enhances our credibility and strengthens the doctor-patient relationship.
Clinical Application: Protocols and Patient Selection
Knowing the “what” and “why” is crucial, but the “how” is what makes the difference in practice. Proper patient selection and meticulous technique are paramount.
Patient Selection and Preparation
Ideal Candidates: Patients with mild-to-moderate (Grade II-III) knee osteoarthritis are often the best candidates. We also see excellent results in chronic tendinopathies and certain shoulder conditions. Pre-Injection Aspiration: If a joint, particularly the knee, has a significant effusion (excess fluid), it is critical to aspirate it before injecting. This “sludge” is filled with inflammatory cytokines and proteases. Removing it cleans the slate, allowing the PRP and PC to work in a less hostile environment.
Injection Volume and Technique
It’s important to understand the volume capacity of different joints. Research presented at conferences has shown that the knee can hold a surprisingly large volume, close to 100 mL, before intra-articular pressure rises dangerously. Therefore, a 10 mL injection (e.g., 5 mL of PRP and 5 mL of PC) is very safe and well-tolerated. Patients might feel a sense of fullness, but it is not harmful. My general volume protocols are: Knees & Shoulders: These are larger-volume joints. I typically use a 1:1 ratio of PRP to PC. For example, 5 mL of PRP combined with 5 mL of PC for a total of 10 mL injection. Hips, Ankles & Wrists: These are lower-volume joints. I adjust the ratio to prioritize the anabolic signal of PRP while still getting the anti-catabolic benefit of PC. For a hip, I might use a 3:1 ratio, such as 3-4 mL of PRP and 1 mL of PC.
Specific Conditions
Chronic Tendinopathy (e.g., Achilles, Patellar): For these conditions, I perform an intratendinous injection of PRP to stimulate healing within the damaged tendon fibers. I then bathe the surrounding area (the paratenon) with Protein Concentrate to quell the local inflammation that is often a major source of pain. Adhesive Capsulitis (Frozen Shoulder): This is one of my favorite applications. The traditional treatment often involves a corticosteroid injection to reduce pain enough for physical therapy to be tolerated. However, we can achieve a better, safer outcome. The protocol involves performing a hydrodilation—stretching the contracted shoulder capsule with sterile saline—followed by an intra-articular injection of Protein Concentrate. The PC’s potent anti-inflammatory effects, especially IL-1Ra, dramatically reduce the inflammation driving the condition, providing a window for effective, less painful rehabilitation.
The Indispensable Role of Chiropractic Care and Rehabilitation
A regenerative injection, no matter how advanced, is only one piece of the puzzle. At my clinic, we are staunch advocates for a holistic approach. Simply performing an injection and sending the patient on their way is what I call “drive-through” medicine, and it’s a disservice to the patient. True healing requires a comprehensive strategy. This is where integrative chiropractic care becomes essential. Restoring Biomechanics: An injury or degenerative condition doesn’t happen in a vacuum. It is almost always associated with or exacerbated by underlying biomechanical faults—poor joint alignment, muscle imbalances, and dysfunctional movement patterns. Chiropractic adjustments are crucial for restoring proper joint mechanics in the spine and extremities. If we inject a knee but fail to address the pelvic imbalances or foot pronation that caused the abnormal stress on that knee, the problem will inevitably return. Improving Neurological Function: Adjustments also have a profound effect on the nervous system, improving proprioception (the body’s sense of its position in space) and normalizing nerve signaling to the muscles that support the joint. This creates a more stable and functional environment for the healing tissues. Targeted Rehabilitation: Following the injection, a structured rehabilitation program is non-negotiable. This must include specific exercises to strengthen supporting muscles, stretch tight structures, and retrain proper movement patterns. The injection creates the optimal biochemical environment for healing, but the physical work of rehab provides the necessary mechanical stimuli to guide tissue remodeling.
Data Collection: The Key to Clinical Excellence
How do you know if your treatments are working? How can you confidently tell a patient what to expect? The answer is data. In my practice, we collect outcome data on every single regenerative procedure. Whether you use a simple spreadsheet or a sophisticated registry service, the act of collecting data is what transforms you from a practitioner who is guessing into one who knows. My own data comparing PRP-only treatments to PRP + PC treatments for knee osteoarthritis show a clear advantage for the combination therapy. Patients in the PRP + PC cohort demonstrate a greater reduction in pain scores and a faster return to function. For example, we can tell a patient that on average, they can expect a 24-point improvement on a specific outcome score by a certain time point. This is powerful. It allows you to: Set realistic patient expectations. Refine and improve your protocols. Leverage your own results during patient consultations to build immense confidence and trust. When I sit with a patient, I can show them our clinic’s data for patients with their exact condition. This is infinitely more valuable than citing a study done by someone else in a different setting. Without your own data, you are flying blind.
Final Thoughts: Delivering a Superior Standard of Care
In a world where PRP is becoming a commodity, you can set your practice apart by delivering a structured, evidence-informed, and comprehensive system of care. Combining the anabolic power of PRP with the anti-catabolic and anti-inflammatory protection of Protein Concentrate creates a synergistic therapy with the potential for significantly better and longer-lasting outcomes. This is not just about an injection. It is about an integrated protocol that you have developed, tested, and proven with your own data. It’s about understanding biomechanics through a chiropractor’s eye, guiding rehabilitation with a therapist’s knowledge, and managing biology with cutting-edge regenerative techniques. This distinction—delivering an integrated system of excellence rather than just a single product—is the foundation of a premium practice and, most importantly, the key to achieving the best possible results for the patients who place their trust in us.
Mei-Dan, O., Carmont, M. R., Laver, L., Mann, G., Maffulli, N., & Nyska, M. (2012). Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. The American Journal of Sports Medicine, 40(3), 534–541. https://journals.sagepub.com/doi/10.1177/0363546511431238
SEO Tags: Protein Concentrate, PRP Therapy, Integrative Chiropractic Care, Knee Osteoarthritis, Regenerative Medicine, Alpha-2-Macroglobulin, A2M, Sports Medicine, Dr. Alexander Jimenez, Functional Medicine, Chronic Tendinopathy, Adhesive Capsulitis, Evidence-Based Practice, Patient Outcomes, Joint Pain Treatment, Non-Surgical Treatment
Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.
Abstract: A New Paradigm in Metabolic Health
Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.
Rethinking Diabetes: Beyond Glucose-Centric Care
In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.” This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.
Pillars of Modern Diabetes Management
The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on: Lifestyle Management: Foundational changes in diet and physical activity. Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition. Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels. Weight Management: Addressing excess weight as a key driver of metabolic dysfunction. Smoking Cessation: Eliminating a major accelerator of cardiovascular disease. This holistic view is the cornerstone of effective, 21st-century care.
Clinical Case Study: The Challenge of “Over-Basalization”
To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi. Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be. A1c: Her last A1c was 8.3%, well above the target of less than 7%. Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress. Medications: Metformin 1000 mg twice daily. Degludec insulin (a basal insulin): 66 units daily. An SGLT-2 inhibitor (a class of oral diabetes medication). A statin for cholesterol. An ARB for blood pressure. Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category. Glucose Readings: Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL. Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.
The Problem: Over-Basalized and Still Not at Goal
Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized. The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.
Understanding GLP-1 Receptor Agonists: The Incretin Effect
To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine. This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response: Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications. Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream. Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals. Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness. In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.
Mechanisms of Action: More Than Just Blood Sugar Control
The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects. Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain. Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying. Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.
The “Ominous Octet” and the Power of GLP-1s
In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.
Choosing the Right GLP-1 Agonist: A Comparative Look
The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy: Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c. Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms. Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%. Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c. It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026: Medication (Brand Name) Key Indications & Benefits A1c Lowering Typical Weight Loss Semaglutide (Ozempic/Rybelsus) Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits. ~1.5-2.0% ~15% of body weight Tirzepatide (Mounjaro/Zepbound) Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising. >2.0% >20% of body weight Dulaglutide (Trulicity) Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents. ~1.0-1.5% ~3-5 kg Liraglutide (Victoza) Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda). ~1.1% ~2.5 kg Exenatide (Byetta/Bydureon) Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents. <1.0% ~2.9 kg MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.
When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.
Cardiovascular Outcomes Trials (CVOTs): The Game-Changer
The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system. What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data: REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE). LEADER Trial (Liraglutide): Showed a 13% reduction in MACE. SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE. These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.
How Professional Guidelines Position GLP-1 Agonists
The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024). The ADA treatment algorithm is divided into two main pathways: The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin. The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile. For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.
Balancing Body and Metabolism- Video
Navigating the Switch: A Guide to Changing GLP-1 Agonists
As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach. Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg. Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.
The Expanding Universe of GLP-1 Receptor Agonists
The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.
One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.
Expanding Indications: Beyond Diabetes
The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials: STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023). SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.
Cravings, Compulsive Behaviors, and Addiction
A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.
PCOS, Fertility, and the “Ozempic Babies” Phenomenon
For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”
Other Investigational Uses
Researchers are also observing positive effects in: Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain. Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020). Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.
The Role of Integrative Chiropractic Care
This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness. Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection. Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises. Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels. Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.
Safety, Side Effects, and Practical Recommendations
While transformative, these medications require careful management.
Common GI Side Effects
Nausea: This is the most common side effect, often linked to early satiety. Constipation or Diarrhea: The effect on motility varies by individual. Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.
Important Safety Issues
Gallbladder Events: Rapid weight loss can increase the risk of gallstones. Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical. Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention. Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents. Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.
Black Box Warning: Thyroid C-Cell Tumors
These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Final Thoughts: A New Hope for Patients
The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke. As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.
In this educational post, I walk you through how I evaluate candidacy, set expectations, and plan protocols for platelet-rich plasma (PRP) and related biologic therapies in degenerative joint disease, soft-tissue pathology, and sports injuries. Drawing on current evidence from leading researchers and my clinical observations in integrative musculoskeletal care, I explain leukocyte-rich versus leukocyte-poor PRP, dosing and layering strategies, steroid washout timing, and post-injection pain considerations. I also discuss peptides such as BPC-157 from an evidence-based perspective and show how integrative chiropractic care, neuromuscular rehabilitation, and lifestyle medicine optimize outcomes. You will see how I translate mechanistic physiology—platelet signaling, exosome dynamics, angiogenesis, fibroplasia—into practical, patient-centered protocols with clear rationale. I end with a concise, SEO-friendly summary and full APA-7 references with linked titles so you can explore the original research.
Patient Candidacy for PRP: Symptoms, Not Strict Cutoffs
When patients ask whether there are hard cutoffs for PRP candidacy—BMI, age, arthritis severity—my answer is that I prioritize symptom phenotype over rigid metrics.
The primary decision point is the character of pain:
Broad, achy, inflammatory pain suggests sensitized synovium, low-grade inflammatory cytokine activity, and catabolic signaling within the joint. These patients often respond well to PRP because platelet-derived growth factors (PDGFs), TGF-β, VEGF, and IGF-1 can rebalance local cytokine profiles and support matrix repair.
Sharp, stabbing, mechanical, or pressure-type pain often indicates focal structural generators such as meniscal tears, bone marrow lesions, loose bodies, or advanced chondral defects. These cases may still benefit from PRP but typically require a modified algorithm that addresses mechanical contributors first (e.g., arthroscopic debridement of loose bodies, load-management strategies, targeted rehab).
Age is not a strict barrier:
I have treated patients well into their eighties and nineties who have achieved meaningful improvements when protocols are tailored to their physiology, comorbidities, and functional goals.
Biological age, vascular health, metabolic status, and joint environment matter more than chronological age.
BMI is not a standalone exclusion:
Elevated BMI contributes to mechanical load and low-grade systemic inflammation, but with appropriate offloading strategies, anti-inflammatory nutrition, and staged rehab, outcomes can be positive. We address metabolic drivers integratively.
Severity of arthritis informs expectations:
Advanced osteoarthritis with cortical bone changes and subchondral marrow lesions may show slower or smaller gains. I counsel patients honestly about expected effect sizes (e.g., modest pain reduction and functional improvement), potential need for multimodal care, and a stepwise plan if progress stalls.
Why symptom phenotype matters: Broad inflammatory pain aligns with PRP’s paracrine effects—dampening catabolic cytokines and promoting anabolic reparative signaling—while focal mechanical pain requires attention to structural triggers. Matching mechanism to phenotype improves success rates.
Setting Realistic Expectations and Timeframes
Patients deserve clear expectations. I often frame outcomes in probabilistic terms based on the literature and my experience:
Typical response rates with intra-articular PRP for knee OA range from about 30% to 60%, achieving clinically meaningful improvements in pain and function over 3 to 6 months, with variability based on PRP preparation, dosing, and patient factors (Filardo et al., 2022).
I emphasize that “nothing I do is 100%.” Biologics reduce pain and improve function, but responses vary. Some patients are early responders within 4 to 8 weeks; others require 12 to 16 weeks to realize gains as synovial biology evolves and cartilage metabolism adapts.
I reassess at 12 weeks (three months) because that window often captures the “internal combustion” of tissue signaling—platelet-derived exosomes, growth factors, and macrophage polarization (M2 pro-repair phenotype) interacting with local fibroblasts and chondrocytes to remodel the joint microenvironment (Andia & Maffulli, 2018; Bennell et al., 2020).
Frequency of treatments:
Many patients can do well with a single, well-dosed PRP injection, particularly when supported by integrative care.
Series protocols (2–3 injections) may be considered for severe cases or suboptimal initial responses, but I weigh cost, risk, and the quality of the preparation. There is no universal mandate; dosing is individualized.
Leukocyte-Rich vs Leukocyte-Poor PRP: Mechanisms and Use-Cases
The leukocyte profile in PRP meaningfully affects the inflammatory trajectory after injection.
Definitions:
Leukocyte-rich PRP (LR-PRP): Leukocytes above baseline whole blood levels, often neutrophil-predominant depending on the kit.
Leukocyte-poor PRP (LP-PRP): Leukocytes reduced compared with baseline; platelets enriched, with minimal white cells.
Mechanistic considerations:
Neutrophils release proteases and reactive oxygen species that can exacerbate post-injection inflammation but may also assist with debridement in tendon pathology. Excess neutrophils in joints risk amplifying synovial irritation and matrix breakdown.
Monocytes/macrophages modulate healing. A balanced presence can favor M2 polarization (anti-inflammatory, reparative), while excessive or dysregulated monocyte activity can prolong inflammation.
Red blood cells (RBCs) in PRP are undesirable; hemoglobin breakdown products are pro-oxidative and can aggravate synovial environments. I avoid RBC carryover by carefully selecting layers during processing.
Practical guidance:
For intra-articular injections (e.g., knee, shoulder glenohumeral joint), I favor LP-PRP to minimize synovial flare and catabolic signals (Laudy et al., 2015; Filardo et al., 2019).
For tendinopathies (e.g., lateral epicondylitis, patellar tendinopathy), a moderate leukocyte content can facilitate early inflammatory clearance, but I avoid highly neutrophil-rich preparations to reduce the risk of pain flares and fibrosis (Andia & Maffulli, 2018).
Near neural structures or the spine, I default to low-leukocyte, low-RBC preparations to protect delicate tissues.
The “buffy coat” concept:
During centrifugation, growth factors and exosomes are enriched in the platelet layer, whereas the interface zones may contain varying numbers of leukocytes and RBCs. Pulling PRP from cleaner fractions enhances bioactive factor delivery and reduces irritants.
Dosing, Layering, and Volume Strategies
More volume is not always better; concentration and composition matter.
Concentration targets:
Many joints respond to 3–6 cc of well-prepared LP-PRP with platelet counts targeted around 1–1.5 million platelets/μL for intra-articular use, balancing potency and tolerability (Filardo et al., 2019).
Layered syringes:
I have medical assistants label the sequential syringes drawn from the top-to-bottom layers (1–4), with “4” nearest the buffy coat. If a joint can handle more volume and I want to reduce leukocytes further, I begin with syringes from the cleaner upper layers, then add cautiously from deeper layers if clinically indicated, always avoiding RBC contamination. This gives graded control over the protein and cell profile.
Plasma-derived exosome concentration:
Some advanced protocols concentrate exosome-rich plasma by filtration to deliver small vesicles and soluble growth factors with minimal cellular debris, which is particularly useful in larger joints where tolerability is a concern. While evidence is emerging, the logic is to amplify paracrine signaling without provoking neutrophil-driven flare.
Steroid Washout Timing Before PRP
Corticosteroids can blunt platelet signaling and cell migration, so I observe washout intervals based on residency:
Intra-articular steroids: I wait a minimum of 32–35 days before PRP, allowing steroid activity to recede so platelet-derived signals are not antagonized (Werner et al., 2017).
Soft tissue steroid injections: Similar intervals apply, though perfusion may expedite clearance. I still schedule PRP beyond four weeks to protect signal integrity.
Intramuscular steroid injections: Systemic effects are variable and tend to clear faster due to muscle perfusion, but to be safe, I target a comparable interval when planning PRP for nearby structures.
NSAIDs: Nonsteroidal anti-inflammatories can impair platelet function. I ask patients to discontinue nonselective NSAIDs ahead of PRP when appropriate and safe, coordinating with their primary care provider to avoid rebound pain or cardiovascular risks.
Post-Injection Pain, Swelling, and Frozen Shoulder Considerations
Patients often ask whether LR-PRP causes more pain. In general:
LP-PRP yields a lower post-injection flare in joints.
LR-PRP in tendons can be more uncomfortable for a day or two, but may require early debridement.
Swelling is typically transient, lasting 24 to 72 hours.
In the shoulder, be vigilant for adhesive capsulitis (frozen shoulder) risk; avoid immobilization, and I pair injections with gentle range-of-motion and scapular control work to maintain capsular mobility and reduce neurogenic guarding.
Peptides Like BPC-157: What the Evidence Says
Patients frequently ask about combining PRP with BPC-157 or other peptides. My stance is conservative and evidence-based:
BPC-157 has preclinical evidence of promoting angiogenesis, modulating nitric oxide levels, and potentially influencing fibroblast migration (Joksimović et al., 2020). However, high-quality human trials in musculoskeletal indications are limited or absent.
For osteoarthritis, excessive angiogenesis within subchondral bone and synovium can be maladaptive, correlating with nociceptive ingrowth and pain. Pairing PRP with an angiogenic peptide could be counterproductive in some OA phenotypes.
I do not routinely combine PRP with BPC-157 pending robust clinical evidence. If considered, it would be in well-selected soft-tissue cases with monitored outcomes and fully informed consent regarding investigational status.
Statins and Muscle Repair: Nuanced Considerations
Some patients report muscle pain on statins. Mechanistically:
Statins can impair CoQ10 and mitochondrial function, potentially affecting muscle energetics. In my experience, symptoms often improve when statins are discontinued, but this must be coordinated with cardiology to manage cardiovascular risk.
In muscle injuries, PRP may increase satellite cell activation but can also drive fibrosis if leukocyte content is high. Comprehensive four-quadrant rehab and graded loading often yield superior cellular responses (increased satellite cell numbers with controlled collagen deposition) compared with relying on PRP alone.
Single vs Series PRP Injections: Risk, Cost, and Efficacy
Single injection:
Lower cost, fewer needle passes, reduced infection risk per episode.
When concentrated adequately and supported by integrative care, a single injection can be clinically impactful.
Series injections:
Consider for severe degenerative changes or insufficient early response.
Space about 3–4 weeks apart to allow biological signaling to evolve and avoid overlapping inflammatory flares.
Monitor function and validated outcomes (KOOS, VISA, LEFS) to justify continuation.
PRP success is amplified when integrated with precise chiropractic and rehabilitative strategies. At Chiromed.com and in my clinic, we combine manual care, movement retraining, and lifestyle medicine:
Regional interdependence:
Correcting kinetic chain faults—hip abductor weakness, tibial external rotation bias, foot pronation—influences joint load and tissue strain. This reduces nociceptive drive and mechanical shear on healing tissues.
Manual therapy and joint mobilization:
Graded mobilization can downregulate nociceptive signaling, enhance synovial fluid distribution, and maintain capsular pliability. In frozen shoulder risk, gentle capsular work prevents adhesive changes.
Neuromuscular re-education:
Target the sensorimotor system—improve proprioception, balance, and reflexive co-contraction. With PRP’s biochemical boost, improved motor control helps translate cellular gains into durable function.
Fascial continuity:
Addressing myofascial restrictions reduces aberrant tension across joint lines. Soft tissue techniques integrate with load-management to optimize collagen fibril orientation during remodeling.
Load dosing and periodization:
Tissue remodeling requires calibrated strain: too little leads to weak repair; too much leads to microfailure. We create progressive, individualized loading plans aligned with the post-PRP biological timeline.
Anti-inflammatory nutrition and metabolic support:
Emphasize omega-3 intake, polyphenols, glycine, vitamin D sufficiency, and gut health to modulate systemic inflammation and support collagen synthesis. Weight management reduces joint load and systemic cytokine levels.
Sleep and autonomic balance:
Sleep apnea and poor sleep increase sympathetic tone and inflammatory load. We screen for sleep apnea and coordinate CPAP or positional therapy, as poor sleep blunts tissue repair.
Exosomes, Plasma Proteins, and “Top-Layer” Strategies
Some clinicians consider augmenting joint volume by adding platelet-poor plasma or filtered exosome-rich fractions:
Rationale:
Exosomes carry microRNAs and proteins that modulate chondrocyte and synoviocyte behavior. Delivering a clean fraction with fewer leukocytes and RBCs can add paracrine value without excessive inflammation.
Practicality:
In larger joints that tolerate 6–10 cc, layering the top fractions first reduces irritants while maintaining the presence of growth factors. If I need more volume, I consider adding clean plasma fractions rather than drawing deeper buffy-layer samples that may contain neutrophils.
Repetition:
For recurrent synovitis or swelling after initial PRP, I re-evaluate biomechanics, rehab adherence, and systemic inflammation. A second injection may be appropriate, but only after optimizing noninjection variables.
Case Touchpoints: Lessons from the Clinic
Loose bodies in elderly patients:
Mechanical symptoms—catching, locking—point to intra-articular loose bodies. Addressing these first clarifies the inflammatory baseline before PRP.
Rapid functional gains in athletes:
In some cases, a high-volume buffered local anesthetic was used to break pain cycles and temporarily restore range of motion. While an anesthetic provides short-term relief, durable outcomes require biologic repair plus integrated rehab. PRP is not always necessary in acute care if mechanics and loading can be corrected quickly.
Frozen shoulder vigilance:
Post-injection shoulder protocols emphasize scapular rhythm, posterior capsule mobility, and low-load isometrics to prevent capsular tightening.
Why We Choose Each Technique: The Physiological Underpinnings
PRP selection:
The key is aligning the PRP’s signal composition with the tissue environment. Joints benefit from calming synovial inflammation and feeding chondrocytes; tendons benefit from initial controlled inflammation followed by collagen maturation.
Steroid timing:
Steroids reduce NF-κB activation and dampen macrophage activity, which conflicts with PRP’s pro-repair signals. Waiting ensures better signal fidelity.
Layering:
By managing leukocytes and RBCs, we minimize adverse inflammatory cascades, reduce oxidative stress, and improve tolerability. Cleaner fractions elevate growth factor-to-irritant ratio.
Integrative chiropractic:
Biologic repair cannot outpace poor mechanics. Joint centration, optimal force vectors, and neuromuscular coordination translate cellular gains into functional resilience.
Stepwise Protocol I Use in Practice
Assessment:
Pain phenotype (achy vs sharp), mechanical triggers, imaging for marrow lesions or meniscal pathology, metabolic and sleep status.
Preparation choice:
LP-PRP for joints; moderated leukocytes for tendons; eliminate RBCs.
Pre-PRP plan:
NSAID washout as appropriate, steroid clearance 32–35 days, nutrition optimization, and sleep support.
Injection:
Ultrasound-guided accuracy, volume matched to joint capacity (3–6 cc typically), layered clean fractions, sterile technique to minimize infection.
Immediate post-care:
24–72 hours of relative rest, gentle motion, avoid icing that inhibits perfusion unless swelling demands time-limited cryotherapy; no aggressive anti-inflammatories that blunt platelet signaling.
Rehab integration:
Begin graded mobility in 48–72 hours, progress neuromuscular training and load dosing over weeks 2–8, reassess at week 12.
Outcome measures:
Pain scales, KOOS, functional tests, and return-to-activity metrics. Adjust plan based on data and patient goals.
What I Tell Patients
On 2026-05-02, I discuss likelihoods plainly: a 30–60% chance of meaningful improvement by the 3–4-month mark for appropriately selected joint cases; higher odds for classic inflammatory pain phenotypes; and lower odds for purely mechanical or advanced degenerative pain unless we fix mechanical generators. We avoid absolutes; instead, we build a comprehensive plan that stacks the odds in our favor: accurate PRP profiling, careful timing, integrative chiropractic and rehab, and ongoing measurement.
Key Takeaways
Use symptom phenotype to guide PRP candidacy; do not rely solely on age, BMI, or arthritis grade.
Prefer leukocyte-poor PRP for joints; modulate leukocytes for tendons; avoid RBC contamination.
Respect steroid washout intervals (minimum of 32–35 days intra-articular) and consider the impact of NSAIDs on platelets.
Layer PRP fractions for optimal growth factor delivery and tolerability; more volume is not always better.
Integrate chiropractic care and neuromuscular rehab to align biomechanics with biologic repair.
Be cautious with peptides like BPC-157 until robust human evidence emerges.
Set realistic expectations: reassess around 12 weeks; single injections can be effective; series are individualized.
Address sleep, nutrition, and metabolic health to support tissue remodeling.
